,Name,smiles,labels
0,Cromolyn Sodium,[Na+].OC(COC1=CC=CC2=C1C(=O)C=C(O2)C([O-])=O)COC1=CC=CC2=C1C(=O)C=C(O2)C([O-])=O,0.25
1,Pitavastatin Calcium,[Ca++].O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC([O-])=O,4.59
2,Enfuvirtide,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,2.76125
3,Cefmenoxime Hydrochloride,Cl.CO\N=C(C(=O)N[C@H]1[C@H]2SCC(CSC3=NN=NN3C)=C(N2C1=O)C(O)=O)\C1=CSC(N)=N1,1.316375
4,Pembrolizumab,n,573.6
5,Pentostatin,OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1NC=NC[C@H]2O,9.713617021
6,Rosiglitazone Maleate,OC(=O)\C=C/C(O)=O.CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=NC=CC=C1,3.48372093
7,Azlocillin Sodium,[Na+].[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCNC1=O)C1=CC=CC=C1)C([O-])=O,1.801
8,Efmoroctocog Alfa,n,16.85095238
9,Estramustine Phosphate Sodium,[Na+].[H][C@]12CC[C@]3(C)[C@H](CC[C@@]3([H])[C@]1([H])CCC1=C2C=CC(OC(=O)N(CCCl)CCCl)=C1)OP([O-])([O-])=O,3.369230769
10,Bevantolol,COC1=CC=C(CCNCC(O)COC2=CC=CC(C)=C2)C=C1OC,1.87
11,Letrozole,N#CC1=CC=C(C=C1)C(N1C=NC=N1)C1=CC=C(C=C1)C#N,45.4
12,Difelikefalin Acetate,CC(O)=O.CC(C)C[C@@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O,23
13,Lamifiban,NC(=N)C1=CC=C(C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC(CC1)OCC(O)=O,2.1
14,Iodixanol,CC(=O)N(CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I,2.348695652
15,Losartan Potassium,[K+].CCCCC1=NC(Cl)=C(C[O-])N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1,2.304
16,Rabeprazole Sodium,[Na+].COCCCOC1=C(C)C(CS(=O)C2=NC3=CC=CC=C3[N-]2)=NC=C1,0.926533333
17,Temsirolimus,[H][C@@]12CCCCN1C(=O)C(=O)[C@]1(O)O[C@@H](CC[C@H]1C)C[C@H](OC)\C(C)=C\C=C\C=C\[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)\C(C)=C\[C@@H](C)C(=O)C[C@H](OC2=O)[C@H](C)C[C@@H]1CC[C@@H](OC(=O)C(C)(CO)CO)[C@@H](C1)OC,30.128
18,Busulfan,CS(=O)(=O)OCCCCOS(C)(=O)=O,2.817667638
19,Clindamycin Hydrochloride,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl.Cl,3.155
20,Alprazolam,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,14.76
21,Chlorambucil,OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl,1.21575
22,Enalaprilat,C[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,29.33333333
23,Ofloxacin,CC1COC2=C(N3CCN(C)CC3)C(F)=CC3=C2N1C=C(C(O)=O)C3=O,5.065
24,Pegloticase,n,250.1525424
25,Cabazitaxel,CC(C)=O.[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C4=CC=CC=C4)C(C)=C([C@@H](OC)C(=O)[C@]1(C)[C@H](C[C@H]1OC[C@@]21OC(C)=O)OC)C3(C)C,103.7127083
26,Levofloxacin,C[C@H]1COC2=C(N3CCN(C)CC3)C(F)=CC3=C2N1C=C(C(O)=O)C3=O,7.009875
27,Dalfampridine,NC1=CC=NC=C1,3.6
28,Vasopressin,N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O,0.24675
29,Eptinezumab,n,648
30,Butorphanol Tartrate,O[C@@H]([C@H](O)C(O)=O)C(O)=O.OC1=CC2=C(C[C@H]3N(CC[C@@]22CCCC[C@@]32O)CC2CCC2)C=C1,4.866333333
31,Entacapone,CCN(CC)C(=O)C(\C#N)=C\C1=CC(=C(O)C(O)=C1)N(=O)=O,2.403333333
32,Lomitapide Mesylate,CS(O)(=O)=O.FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C2=CC=CC=C2C2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C2C2=C1C=CC=C2,26.56
33,Ethacrynic Acid,CCC(=C)C(=O)C1=CC=C(OCC(O)=O)C(Cl)=C1Cl,0.3135
34,Pazopanib Hydrochloride,Cl.CN1N=C2C=C(C=CC2=C1C)N(C)C1=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=NC=C1,27.23333333
35,Phenytoin,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,14.06661905
36,Bumetanide,CCCCNC1=CC(=CC(=C1OC1=CC=CC=C1)S(N)(=O)=O)C(O)=O,3.447222222
37,Anakinra,CC(C)(C)C(=O)OCO/N=C(\C1=CSC(=N1)N)/C(=O)NC2C3N(C2=O)C(=C(CS3)C=C)C(=O)O,2.813333333
38,Efungumab,n,0.633333333
39,Gemtuzumab Ozogamicin,n,60.13571429
40,Terbutaline Sulfate,OS(O)(=O)=O.CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1,13.7
41,Domperidone,ClC1=CC=C2N(C3CCN(CCCN4C(=O)NC5=CC=CC=C45)CC3)C(=O)NC2=C1,7.5
42,Nintedanib Esylate,CCS(O)(=O)=O.COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1,17.9
43,Clindamycin Phosphate,OP(O)(O)=O.CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O,1.9488
44,Bimatoprost,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,0.75496875
45,Technetium Tc-99m Pyrophosphate Kit,n,4.5
46,Sirolimus,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]1CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1)OC,50.9775
47,Tisagenlecleucel-T,n,289.0153846
48,Latanoprost,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,0.909125
49,Oxybutynin Chloride,Cl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,2
50,Ceftazidime Sodium,[Na+].[H][C@@]12SCC(C[N+]3=CC=CC=C3)=C(N1C(=O)[C@@H]2NC(=O)C(=N/OC(C)(C)C([O-])=O)\C1=CSC(N)=N1)C([O-])=O,1.9
51,Botulism Immune Globulin Intravenous (Human),n,672
52,Daptomycin,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=C(N)C=CC=C2)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,7.78429078
53,Semaglutide,n,137
54,Naltrexone Hydrochloride,Cl.OC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5CC1CC1,2.7
55,Timolol Maleate,OC(=O)\C=C/C(O)=O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1,3.8
56,Buprenorphine,[H][C@@]1(C[C@]23CC[C@@]1(OC)[C@@H]1OC4=C(O)C=CC5=C4[C@]21CCN(CC1CC1)[C@@H]3C5)[C@](C)(O)C(C)(C)C,10.5382125
57,Aminophylline,NCCN.CN1C(=O)N(C)C2=C(NC=N2)C1=O,5.7
58,Methyldopa,C[C@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O,2
59,Phentolamine Mesylate,CS(O)(=O)=O.CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC=CC(O)=C1,1.414285714
60,Haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,16.925
61,Vorinostat,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,0.71
62,Belinostat,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1,1.576733333
63,Dirithromycin,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O,40
64,Lanthanum Carbonate,[La+3].[O-]C([O-])=O,37.38
65,Famotidine,N\C(N)=N/C1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1,2.97173913
66,Amphetamine; Dextroamphetamine,C[C@@H](CC1=CC=CC=C1)N,12
67,Lutropin Alfa,n,10.35714286
68,Pafolacianine Sodium,[Na+].CC1(C)\C(=C/C=C2CCCC(/C=C/C3=[N+](CCCCS([O-])(=O)=O)C4=C(C=C(C=C4)S([O-])(=O)=O)C3(C)C)=C\2OC2=CC=C(C[C@H](NC(=O)C3=CC=C(NCC4=CN=C5NC(N)=NC(=O)C5=N4)C=C3)C([O-])=O)C=C2)N(CCCCS([O-])(=O)=O)C2=C1C=C(C=C2)S([O-])(=O)=O,0.44
69,Fluticasone Furoate,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,15.1075
70,Palivizumab,n,431.4
71,Peginesatide Acetate,n,38.36307692
72,Epoetin Delta,n,5.85
73,Alfuzosin Hydrochloride,Cl.COC1=CC2=NC(=NC(N)=C2C=C1OC)N(C)CCCNC(=O)C1CCCO1,6.3
74,Levonorgestrel,[H][C@]12CCC(=O)C=C1CC[C@]1([H])[C@]2([H])CC[C@@]2(CC)[C@@]1([H])CC[C@@]2(O)C#C,15.2
75,Tamsulosin Hydrochloride,Cl.CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC=C(OC)C(=C1)S(N)(=O)=O,5.057142857
76,Acitretin,COC1=CC(C)=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)=C1C,45.85
77,Atosiban,CCOC1=CC=C(C[C@H]2NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)C=C1,1.285714286
78,Isosorbide Mononitrate,[H][C@]12OC[C@@H](ON(=O)=O)[C@@]1([H])OC[C@@H]2O,4.631166667
79,Solifenacin Succinate,OC(=O)CCC(O)=O.O=C(O[C@H]1CN2CCC1CC2)N1CCC2=C(C=CC=C2)[C@@H]1C1=CC=CC=C1,52.4
80,Ixabepilone,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,44.67141176
81,Micafungin Sodium,[Na+].[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@H](C[C@@H](O)[C@@H](O)NC(=O)[C@]1([H])[C@@H](O)[C@@H](C)CN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C(OS([O-])(=O)=O)=C1)[C@H](O)CC(N)=O)NC(=O)C1=CC=C(C=C1)C1=NOC(=C1)C1=CC=C(OCCCCC)C=C1)[C@@H](C)O,14.20165919
82,Tafasitamab,n,406.4
83,Nebivolol Hydrochloride,Cl.[H][C@@]1(CCC2=CC(F)=CC=C2O1)[C@H](O)CNC[C@@H](O)[C@]1([H])CCC2=CC(F)=CC=C2O1,21.55
84,Oxycodone Hydrochloride,Cl.[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@H](C4)[C@]1(O)CCC2=O,3.62
85,Silodosin,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=C(OCC(F)(F)F)C=CC=C1,3.607
86,Captopril,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,2.155
87,Dolasetron Mesylate,CS(O)(=O)=O.[H][C@@]12C[C@H](C[C@@H]3C[C@H](C1)C(=O)CN23)OC(=O)C1=CNC2=C1C=CC=C2,5.911578059
88,Plerixafor,Cl.C1CNCCNCCCN(CCNC1)CC1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,3.15
89,Gadofosveset Trisodium,O.[Na+].[O-]C(=O)CN1CCN2C[C@H](COP([O-])(=O)OC3CCC(CC3)(C3=CC=CC=C3)C3=CC=CC=C3)N(CC([O-])=O)CC(=O)O[Gd](OC(=O)C2)OC(=O)C1,21.04686047
90,Oseltamivir Phosphate,OP(O)(O)=O.CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,2.598285714
91,Ecallantide,CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2=CNC=N2)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)CNC(=O)CNC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@@H](NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC3=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N3CCC[C@H]3C(=O)N2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC1=O)[C@@H](C)O)[C@@H](C)CC,1.2855
92,Mitoxantrone Hydrochloride,Cl.OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(C2=O)C(O)=CC=C1O,29.57129041
93,Oritavancin,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(NCC5=CC=C(C=C5)C5=CC=C(Cl)C=C5)[C@@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@H]1C(=O)N[C@@H]([C@H](O[C@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)C3=CC(Cl)=C(O4)C=C3)C(=O)N[C@H](C(O)=O)C3=C(C(O)=CC(O)=C3)C3=C(O)C=CC1=C3)C(Cl)=C2,192.3
94,Ustekinumab,n,468.7871429
95,Lisuride,[H][C@@]12CC3=CNC4=C3C(=CC=C4)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,1.5
96,Alectinib Hydrochloride,Cl.CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C2=O)C2=C(N1)C=C(C=C2)C#N,11.7
97,Entecavir,NC1=NC2=C(N=CN2[C@H]2C[C@H](O)[C@@H](CO)C2=C)C(=O)N1,130
98,"Estrogens, Conjugated",C[C@]12CC[C@H]3C(=CCC4=C3C=CC(=C4)OS(=O)(=O)[O-])[C@@H]1CCC2=O.[Na+],3
99,Palonosetron Hydrochloride,Cl.[H][C@@]12CCCC3=CC=CC(C(=O)N(C1)[C@@H]1CN4CCC1CC4)=C23,40.86769231
100,Radium Ra-223 Dichloride,[Cl-].[223Ra++],13.66142857
101,Atorvastatin Calcium,[Ca++].CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC=C2)=C(N1CC[C@@H](O)C[C@@H](O)CC([O-])=O)C1=CC=C(F)C=C1,21
102,Technetium Tc-99m Bicisate Kit,n,20.17774375
103,Ferric Pyrophosphate Citrate,n,1.358571429
104,Insulin Aspart,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC,0.167
105,"Nitroprusside, Sodium",[Na+].O=N[Fe](C#N)(C#N)(C#N)(C#N)C#N,0.033
106,Disopyramide Phosphate,OP(O)(O)=O.CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,6.225
107,Trovafloxacin Mesylate,CS(O)(=O)=O.[H][C@@]12CN(C[C@]1([H])[C@H]2NC(=O)[C@H](C)NC(=O)[C@H](C)N)C1=C(F)C=C2C(=O)C(=CN(C3=CC=C(F)C=C3F)C2=N1)C(O)=O,9.6
108,Iofetamine Hydrochloride I-123,Cl.CC(C)NC(C)CC1=CC=C([123I])C=C1,9.32
109,Nelarabine,COC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O)C2=NC(N)=N1,0.330076923
110,Paclitaxel,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,12.9562908
111,Enoxaparin Sodium,C[C@@H]1[C@H]([C@H](O[C@@H]([C@H]1O[C@@H]2CC([C@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)O)O[C@H]4[C@@H]([C@H](C=C(O4)C(=O)[O-])O)O)O)NC(=O)C)C(=O)[O-])CO)OC5[C@@H]([C@H]([C@@H](OC5C(=O)[O-])OC6[C@H]7CO[C@H](O7)[C@@H]([C@H]6O)NS(=O)(=O)[O-])O)O)NC(=O)C.[Na+].[Na+].[Na+].[Na+],4.259730769
112,Imatinib Mesylate,CS(O)(=O)=O.CN1CCN(CC1)CC1=CC=C(C=C1)C(=O)NC1=CC(NC2=NC(=CC=N2)C2=CN=CC=C2)=C(C)C=C1,21.9
113,Morphine Sulfate,O.OS(O)(=O)=O.[H][C@@]12C=C[C@H](O)[C@@H]3OC4=C(O)C=CC5=C4[C@]13CCN(C)[C@@H]2C5,4.844035294
114,Zoledronic Acid,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,77.56625
115,Lodoxamide Tromethamine,NC(CO)(CO)CO.OC(=O)C(=O)NC1=CC(=CC(NC(=O)C(O)=O)=C1Cl)C#N,0.13
116,Amlodipine Besylate; Valsartan,n,10.66666667
117,Insulin Lispro (Human Analog),n,0.700526316
118,Fulvestrant,[H][C@]12CC[C@]3(C)[C@@H](O)CC[C@@]3([H])[C@]1([H])[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC1=C2C=CC(O)=C1,14.13333333
119,Nitroglycerin,O=N(=O)OCC(CON(=O)=O)ON(=O)=O,0.083
120,Metoprolol Fumarate,OC(=O)\C=C\C(O)=O.COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,2.875
121,Etomidate,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1,2.263333333
122,Cisapride Monohydrate,O.CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC,20
123,Estradiol,[H][C@]12CC[C@]3(C)[C@@H](O)CC[C@@]3([H])[C@]1([H])CCC1=C2C=CC(O)=C1,0.8806
124,Sufentanil Citrate,OC(=O)CC(O)(CC(O)=O)C(O)=O.CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC2=CC=CS2)CC1)COC,4.771333333
125,Cinacalcet Hydrochloride,Cl.C[C@@H](NCCCC1=CC=CC(=C1)C(F)(F)F)C1=C2C=CC=CC2=CC=C1,19.9
126,Rituximab,n,465.5197674
127,Glycopyrrolate,[Br-].C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,3.205117647
128,Nalmefene Hydrochloride,Cl.OC1=C2O[C@H]3C(=C)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5CC1CC1,10.012
129,Nesiritide,CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(O)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)C(C)C,0.307433333
130,Amisulpride,CCN1CCCC1CNC(=O)C1=CC(=C(N)C=C1OC)S(=O)(=O)CC,4.213428571
131,Cefuroxime Axetil,CO\N=C(C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OC(C)OC(C)=O)\C1=CC=CO1,1.433333333
132,Dostarlimab,n,598.2
133,Duloxetine Hydrochloride,Cl.CNCC[C@H](OC1=C2C=CC=CC2=CC=C1)C1=CC=CS1,7.08
134,Imiglucerase,n,0.08340625
135,Lidocaine Hydrochloride,Cl.CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,1.865217391
136,Neostigmine Methylsulfate,COS([O-])(=O)=O.CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,1.243264286
137,Choline C-11,[Cl-].C[N+](C)([11CH3])CCO,0.4
138,Quinine Sulfate,O.OS(O)(=O)=O.[H][C@@]12CCN(C[C@H]1C=C)[C@@]([H])(C2)[C@H](O)C1=CC=NC2=C1C=C(OC)C=C2,12.3625
139,Elotuzumab,n,504.4647059
140,Moxetumomab Pasudotox,n,1.286608696
141,Diclofenac Sodium,[Na+].[O-]C(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,1.685866667
142,Sermorelin Acetate,O.CC(O)=O.CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O,0.190666667
143,Heparin Sodium,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O.[Na+],2.001909722
144,Alglucosidase Alfa,n,2.506
145,Cephradine,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CCC=CC1)C(O)=O,0.9125
146,Larotrectinib,OS(O)(=O)=O.O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCCC1C1=CC(F)=CC=C1F,2.14
147,Netilmicin Sulfate,OS(O)(=O)=O.[H][C@]1(O[C@@H]2[C@@H](N)C[C@@H](NCC)[C@H](O[C@@]3([H])OC[C@@](C)(O)[C@@H](NC)[C@@H]3O)[C@H]2O)OC(CN)=CC[C@H]1N,17.56666667
148,Dexmedetomidine Hydrochloride,Cl.C[C@H](C1=CNC=N1)C1=CC=CC(C)=C1C,2.274872222
149,Eflornithine Hydrochloride,Cl.NCCCC(N)(C(F)F)C(O)=O,3.5
150,Tazobactam,[H][C@@]12CC(=O)N1[C@@H](C(O)=O)[C@](C)(CN1C=CN=N1)S2(=O)=O,2.435
151,Edoxaban Tosylate,O.CC1=CC=C(C=C1)S(O)(=O)=O.CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]1C[C@H](CC[C@@H]1NC(=O)C(=O)NC1=NC=C(Cl)C=C1)C(=O)N(C)C,6.85
152,Safinamide Methanesulfonate,CS(O)(=O)=O.C[C@H](NCC1=CC=C(OCC2=CC=CC(F)=C2)C=C1)C(N)=O,26
153,Copanlisib Dihydrochloride,Cl.COC1=C2N=C(NC(=O)C3=CN=C(N)N=C3)N3CCN=C3C2=CC=C1OCCCN1CCOCC1,38.8
154,Acivicin,[H][C@]1(CC(Cl)=NO1)[C@H](N)C(O)=O,11.12666667
155,Tegaserod Maleate,OC(=O)\C=C\C(O)=O.CCCCCNC(=N)N\N=C/C1=CNC2=C1C=C(OC)C=C2,11
156,Sparfloxacin,C[C@H]1CN(C[C@@H](C)N1)C1=C(F)C2=C(C(=O)C(=CN2C2CC2)C(O)=O)C(N)=C1F,22.1
157,Rasagiline Mesylate,CS(O)(=O)=O.C#CCN[C@@H]1CCC2=CC=CC=C12,1.88
158,Rasburicase,n,15.4875
159,Olodaterol Hydrochloride,Cl.COC1=CC=C(CC(C)(C)NC[C@H](O)C2=C3OCC(=O)NC3=CC(O)=C2)C=C1,22
160,Epinephrine,CNC[C@H](O)C1=CC=C(O)C(O)=C1,0.5665
161,Romosozumab,n,113.04
162,Methylprednisolone,[H][C@@]12C[C@H](C)C3=CC(=O)C=C[C@]3(C)[C@@]1([H])[C@@H](O)C[C@@]1(C)[C@@]2([H])CC[C@]1(O)C(=O)CO,2.1266
163,Albuterol Sulfate,OS(O)(=O)=O.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1,3.95
164,Antithymocyte Globulin (Rabbit),n,48
165,Iopromide,COCC(=O)NC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)N(C)CC(O)CO)=C1I,3.131923913
166,Meloxicam,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=CC=CC=C2S1(=O)=O,20.56131579
167,Soybean Oil,n,0.4252
168,Nomegestrol Acetate; Estradiol,n,3.6
169,Doxacurium Chloride,[Cl-].COC1=CC(C[C@H]2C3=C(CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCC4=C([C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)C(OC)=C(OC)C(OC)=C4)C=C(OC)C(OC)=C3OC)=CC(OC)=C1OC,1.718046512
170,Perflexane Lipid Microspheres,n,7.409090909
171,Didanosine,OC[C@@H]1CC[C@@H](O1)N1C=NC2=C1N=CNC2=O,1.303684211
172,Pegfilgrastim,n,22.33333333
173,Sparteine Sulfate,OS(O)(=O)=O.[H][C@]12CN3CCCC[C@@]3([H])[C@]([H])(CN3CCCC[C@]13[H])C2,5.0875
174,Trastuzumab,n,263.9146774
175,Teniposide,[H][C@@]12CO[C@H](O[C@@]1([H])[C@H](O)[C@@H](O)[C@H](O[C@@H]1C3=C(C=C4OCOC4=C3)[C@@H](C3=CC(OC)=C(O)C(OC)=C3)[C@@]3([H])C(=O)OC[C@]13[H])O2)C1=CC=CS1,8.283513514
176,Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)[C@@H](C(C)C)C(O)=O,6
177,Mitotane,ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=C(Cl)C=CC=C1,432
178,Damoctocog Alfa Pegol,COCCOCC(COCCCNC(=O)CCN1C(=O)CC(C1=O)SC[C@@H](C(=O)O)N)OCCOC,17.26585366
179,Irinotecan Hydrochloride,Cl.CCC1=C2CN3C(=O)C4=C(C=C3C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12)[C@@](O)(CC)C(=O)OC4,6.695645933
180,Lorcainide,CC(C)N1CCC(CC1)N(C(=O)CC1=CC=CC=C1)C1=CC=C(Cl)C=C1,6.633333333
181,Nicotine Polacrilex,CN1CCC[C@H]1C2=CN=CC=C2,8
182,Pemetrexed Ditromethamine,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(=O)NC(CO)(CO)CO)C(=O)NC(CO)(CO)CO)N1,3.5
183,Trandolapril,[H][C@]12CCCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,0.26
184,Inotuzumab Ozogamicin,n,295.2
185,Basiliximab,n,186.7826087
186,Torsemide,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC=CC(C)=C2)C=CN=C1,4.0978
187,Avitriptan,OC(=O)\C=C\C(O)=O.CNS(=O)(=O)CC1=CC2=C(NC=C2CCCN2CCN(CC2)C2=C(OC)C=NC=N2)C=C1,7.315
188,Nepafenac,NC(=O)CC1=CC=CC(C(=O)C2=CC=CC=C2)=C1N,20.4
189,"Iodohippurate Sodium, I-123",[Na+].[O-]C(=O)CNC(=O)C1=CC=CC=C1[123I],0.2085
190,Etoposide,[H][C@@]12CO[C@@H](C)O[C@@]1([H])[C@H](O)[C@@H](O)[C@H](O[C@@H]1C3=C(C=C4OCOC4=C3)[C@@H](C3=CC(OC)=C(O)C(OC)=C3)[C@@]3([H])C(=O)OC[C@]13[H])O2,4.625925926
191,Selegiline,C[C@H](CC1=CC=CC=C1)N(C)CC#C,20.728
192,Tedizolid Phosphate,CN1N=NC(=N1)C1=CC=C(C=N1)C1=C(F)C=C(C=C1)N1C[C@H](COP(O)(O)=O)OC1=O,8.079886792
193,Triamcinolone Acetonide,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,1.47
194,Gadoterate Meglumine,O.C[NH2+]CC(O)C(O)C(O)C(O)CO.[O-]C(=O)C[N]12CC[N]3(CC[N]4(CC[N](CC1)(CC([O-])=O)[Gd+3]234)CC([O-])=O)CC([O-])=O,2.285185185
195,Flibanserin,FC(F)(F)C1=CC=CC(=C1)N1CCN(CC1)CCN1C(=O)NC2=C1C=CC=C2,7.20875
196,Metoclopramide Hydrochloride,Cl.CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,4.45
197,Velmanase Alfa,n,30
198,Ibandronic Acid,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O,12.78
199,Adenosine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,0.00278
200,Ceftriaxone Sodium,[Na+].CO\N=C(C(=O)N[C@H]1[C@H]2SCC(CSC3=NC(=O)C(O)=NN3C)=C(N2C1=O)C([O-])=O)/C1=CSC(N)=N1,6.413030303
201,Eliglustat Tartrate,O[C@H]([C@@H](O)C(O)=O)C(O)=O.CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)C1=CC=C2OCCOC2=C1,6.5
202,Ephedrine Sulfate,OS(O)(=O)=O.CN[C@@H](C)[C@H](O)C1=CC=CC=C1,6
203,Ivabradine Hydrochloride,Cl.COC1=CC2=C(C=C1OC)[C@@H](CN(C)CCCN1CCC3=CC(OC)=C(OC)C=C3CC1=O)C2,6.4
204,Milrinone Lactate,CC(O)C(O)=O.CC1=C(C=C(C#N)C(=O)N1)C1=CC=NC=C1,1.734961538
205,Octreotide Acetate,CC(O)=O.C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,1.38
206,Polymyxin B Sulfate,n,8.69
207,Vindesine,[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C)[C@@]1([H])[C@](O)([C@H](O)[C@]2(CC)C=CC3)C(N)=O)[C@]1(C[C@@H]2C[N@](CCC3=C1NC1=CC=CC=C31)C[C@](O)(CC)C2)C(=O)OC,15.305
208,Betamethasone Sodium Phosphate,[Na+].[H][C@@]12C[C@H](C)[C@](O)(C(=O)COP([O-])([O-])=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,0.079
209,Oxaliplatin,[H][C@@]12CCCC[C@@]1([H])[NH2][Pt]1([NH2]2)OC(=O)C(=O)O1,297.7905
210,Omeprazole Magnesium,[Mg++].COC1=CC=C2[N-]C(=NC2=C1)S(=O)CC1=NC=C(C)C(OC)=C1C,1.44
211,Moxifloxacin Hydrochloride,Cl.[H][C@@]12CCCN[C@]1([H])CN(C2)C1=C(OC)C2=C(C=C1F)C(=O)C(=CN2C1CC1)C(O)=O,10.58
212,Alglucerase,n,0.08
213,Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,0.9
214,Acecainide,CCN(CC)CCNC(=O)C1=CC=C(NC(C)=O)C=C1,9.6
215,Midodrine Hydrochloride,Cl.COC1=CC=C(OC)C(=C1)C(O)CNC(=O)CN,2.4867
216,Ifosfamide; Mesna,n,1.33175
217,Inebilizumab,n,436.32
218,Metoprolol Succinate,OC(=O)CCC(O)=O.COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,4.09
219,Viltolarsen,n,2.5
220,Tildrakizumab,n,615.6
221,Quinidine Gluconate,OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,8.753333333
222,Conivaptan Hydrochloride,Cl.CC1=NC2=C(N1)C1=CC=CC=C1N(CC2)C(=O)C1=CC=C(NC(=O)C2=CC=CC=C2C2=CC=CC=C2)C=C1,6.64
223,Sulfasalazine,OC(=O)C1=C(O)C=CC(=C1)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1,11.35
224,Human Coagulation Factor VII (Activated),n,1.803333333
225,Daratumumab,n,219.5730625
226,Ertugliflozin L-pyroglutamic Acid,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)CO)O)O)O)Cl.C1CC(=O)N[C@@H]1C(=O)O,8.98
227,Probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O,3.658
228,Dalfopristin; Quinupristin,n,1.05775
229,Idarubicin Hydrochloride,Cl.C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(=O)C4=CC=CC=C4C3=O)C(O)=C12)C(C)=O,31.51076923
230,Azacitidine,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,1.394904762
231,Guselkumab,n,382.0777778
232,Napsagatran,NC(=N)N1CCC[C@@H](CNC(=O)C[C@H](NS(=O)(=O)C2=CC3=C(C=CC=C3)C=C2)C(=O)N(CC(O)=O)C2CC2)C1,1.9105
233,Fam-Trastuzumab Deruxtecan,n,135.9608333
234,Apixaban,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O,6.175
235,Romidepsin,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,8.297678571
236,Prucalopride Succinate,OC(=O)CCC(O)=O.COCCCN1CCC(CC1)NC(=O)C1=CC(Cl)=C(N)C2=C1OCC2,19.5
237,Agalsidase Beta,n,1.516333333
238,Eravacycline dihydrochloride,Cl.[H][C@@]12CC3=C(F)C=C(NC(=O)CN4CCCC4)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,17.774
239,Aprepitant,C[C@@H](O[C@H]1OCCN(CC2=NC(=O)NN2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,9
240,Tocilizumab,n,190.3420513
241,Velaglucerase Alfa,n,0.187428571
242,Asparaginase,n,27.42545556
243,Fish Oil; Medium Chain Triglycerides; Olive Oil; Soybean Oil,n,0.175
244,Theophylline,CN1C(=O)N(C)C2=C(NC=N2)C1=O,8.311422727
245,Meropenem; Vaborbactam,n,1.637299
246,Mivacurium Chloride,[Cl-].COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C(OC)=C1)[N+](C)(CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C(OC)=C1)CC2,0.562
247,Daunorubicin; Cytarabine,n,30.5551087
248,Asfotase Alfa,n,87.2
249,Lormetazepam,CN1C(=O)C(O)N=C(C2=CC=CC=C2Cl)C2=CC(Cl)=CC=C12,9.1
250,Plazomicin Sulfate,OS(O)(=O)=O.[H][C@@]1(OC[C@](C)(O)[C@H](NC)[C@H]1O)O[C@H]1[C@@H](C[C@H](N)[C@@]([H])(O[C@H]2OC(CNCCO)=CC[C@H]2N)[C@@H]1O)NC(=O)[C@@H](O)CCN,9.661904762
251,Eculizumab,n,259.3376667
252,Brexanolone,[H][C@@]12CC[C@@]3([H])[C@]4([H])CC[C@H](C(C)=O)[C@@]4(C)CC[C@]3([H])[C@@]1(C)CC[C@@H](O)C2,8.434210526
253,Acetaminophen,CC(=O)NC1=CC=C(O)C=C1,2.767913043
254,Mifamurtide,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC,10.0225
255,Turoctocog Alfa Pegol,n,16.13125
256,Indomethacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,14.02777778
257,Enasidenib Mesylate,CS(O)(=O)=O.CC(C)(O)CNC1=NC(NC2=CC(=NC=C2)C(F)(F)F)=NC(=N1)C1=NC(=CC=C1)C(F)(F)F,28.3
258,Saquinavir,[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)C1=CC=C3C=CC=CC3=N1)[C@@H](C2)C(=O)NC(C)(C)C,11.5
259,Prazosin Hydrochloride,Cl.COC1=CC2=NC(=NC(N)=C2C=C1OC)N1CCN(CC1)C(=O)C1=CC=CO1,2.749166667
260,Teduglutide Recombinant,n,1.65
261,Imipramine Hydrochloride,Cl.CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,17.93
262,Piribedil,C1OC2=CC=C(CN3CCN(CC3)C3=NC=CC=N3)C=C2O1,11.83333333
263,Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,2.8
264,Nizatidine,CN\C(NCCSCC1=CSC(CN(C)C)=N1)=C\N(=O)=O,1.333333333
265,Dantrolene Sodium,[Na+].[O-]C1=NC(=O)CN1\N=C\C1=CC=C(O1)C1=CC=C(C=C1)N(=O)=O,10.12448485
266,Posaconazole,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@@](C2)(CN2C=NC=N2)C2=C(F)C=C(F)C=C2)C=C1,18.64405405
267,Fibrinogen,n,69.81275
268,Cyclosporine,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,7.161111111
269,Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=CC(Cl)=CC=C2NC1=O,14.1056
270,Cinoxacin,CCN1N=C(C(O)=O)C(=O)C2=CC3=C(OCO3)C=C12,1.5
271,Prednisolone,[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])[C@@H](O)C[C@@]1(C)[C@@]2([H])CC[C@]1(O)C(=O)CO,2.785
272,Lefamulin Acetate,CC(O)=O.[H][C@@]12C(=O)CC[C@]11CC[C@@H](C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]1C)OC(=O)CS[C@@H]1CC[C@@H](N)C[C@H]1O,10.35552727
273,Mitomycin,CO[C@]12[C@H]3N[C@H]3CN1C1=C([C@H]2COC(N)=O)C(=O)C(N)=C(C)C1=O,0.4766
274,Midazolam,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C3=C(C=CC(Cl)=C3)N12,5.17871875
275,Isatuximab,n,392.0868
276,Gatifloxacin,COC1=C(N2CCNC(C)C2)C(F)=CC2=C1N(C=C(C(O)=O)C2=O)C1CC1,11.08380952
277,Mepolizumab,n,571.35
278,Promethazine Hydrochloride,Cl.CC(CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C,12.2
279,Fosdenopterin Hydrobromide,Br.[H][C@@]12COP(O)(=O)O[C@]1([H])C(O)(O)[C@]1([H])NC3=C(N[C@]1([H])O2)N=C(N)NC3=O,1.386
280,Ioversol,OCCN(C(=O)CO)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I,1.676
281,Nefazodone Hydrochloride,Cl.CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1,7.1
282,Vincristine Sulfate,OS(O)(=O)=O.[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@H]2C[N@](CCC3=C1NC1=CC=CC=C31)C[C@](O)(CC)C2)C(=O)OC,13.50545455
283,Midazolam Hydrochloride,Cl.CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=CC(Cl)=CC=C3N12,3.432142857
284,Belantamab Mafodotin,n,215.1873684
285,Diazepam,CN1C(=O)CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C12,44.6601626
286,Cytarabine,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,1.295545455
287,Cephalothin Sodium,[Na+].CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)CC1=CC=CS1)C2=O)C([O-])=O,0.432
288,Zanamivir,[H][C@]1(OC(=C[C@H](NC(N)=N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,2.913514286
289,Divalproex Sodium,[Na+].CCCC(CCC)C(O)=O.CCCC(CCC)C([O-])=O,8.5
290,Ganirelix Acetate,CC(O)=O.CCN\C(NCC)=N\CCCC[C@@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCC\N=C(/NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,11.93333333
291,Samarium Sm 153 Lexidronam,C(CN(CP(=O)(O)O)CP(=O)(O)O)N(CP(=O)(O)O)CP(=O)(O)O.[153Sm],31.36333333
292,Durvalumab,n,417.6
293,Methylene Blue,[Cl-].CN(C)C1=CC2=C(C=C1)N=C1C=C/C(/C=C1S2)=[N+](\C)C,16.65772414
294,Melphalan,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,1.021181818
295,Lincomycin Hydrochloride,Cl.CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@@H](C)O)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O,4.5
296,Hydrochlorothiazide; Valsartan,n,6
297,Daclatasvir Dihydrochloride,Cl.COC(=O)NC(C(C)C)C(=O)N1CCC[C@H]1C1=NC=C(N1)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CN=C(N1)[C@@H]1CCCN1C(=O)C(NC(=O)OC)C(C)C,9.51
298,Vestronidase Alfa,n,2.308192308
299,Follitropin Delta,n,24
300,Lumateperone Tosylate,CC1=CC=C(C=C1)S(O)(=O)=O.[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C,18
301,Raxibacumab,n,513.6735294
302,Penciclovir Sodium,[Na+].NC1=NC2=C(N=CN2CCC(CO)C[O-])C(=O)N1,2
303,Valrubicin,[H][C@@]1(C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=C(C=CC=C3OC)C(=O)C1=C2O)C(=O)COC(=O)CCCC,0.9
304,Ansuvimab,n,671.2
305,Aclidinium Bromide,[Br-].OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1,2.897333333
306,Glipizide,CC1=CN=C(C=N1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,2
307,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,2.051813445
308,Defibrotide Sodium,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O,0.989333333
309,Isoxicam,CN1C(C(=O)NC2=NOC(C)=C2)=C(O)C2=C(C=CC=C2)S1(=O)=O,27.6
310,Enoximone,CSC1=CC=C(C=C1)C(=O)C1=C(C)NC(=O)N1,0.998
311,Erlotinib Hydrochloride,Cl.COCCOC1=CC2=NC=NC(NC3=CC=CC(=C3)C#C)=C2C=C1OCCOC,13
312,Desipramine Hydrochloride,Cl.CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2,22.75
313,Iobenguane I-131,NC(=N)NCC1=CC=CC([131I])=C1,35.70181818
314,Iodine I 131 Tositumomab; Tositumomab,n,65.08
315,Codeine Phosphate,OP(O)(O)=O.[H][C@@]12CC3=C4C(O[C@@]5([H])[C@@H](O)C=C[C@]1([H])[C@@]45CCN2C)=C(OC)C=C3,4.9
316,Deferasirox,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,4.118
317,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C1=C(C(=O)OC1)C1=CC=CC=C1,6.1925
318,Epoetin Beta,n,4
319,Besilesomab,n,20.90714286
320,Rilmenidine,C1CO\C(N1)=N/C(C1CC1)C1CC1,8.31
321,Propofol,CC(C)C1=CC=CC(C(C)C)=C1O,1.745366667
322,Mezlocillin Sodium Monohydrate,O.[Na+].[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(C1=O)S(C)(=O)=O)C1=CC=CC=C1)C([O-])=O,1.124472727
323,Beclomethasone Dipropionate Monohydrate,O.[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,0.5
324,Flutemetamol F-18,CNC1=CC=C(C=C1[18F])C1=NC2=CC=C(O)C=C2S1,2.094416667
325,Gemifloxacin Mesylate,CS(O)(=O)=O.CO\N=C1/CN(CC1CN)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=N1)C(O)=O,9.456818182
326,Metformin Hydrochloride,Cl.CN(C)C(=N)NC(N)=N,6.176090909
327,Natalizumab,n,176.0787209
328,Remdesivir,CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C1=CC=C2N1N=CN=C2N)OC1=CC=CC=C1,0.974545455
329,Peginterferon Alfa-2a,n,58.33333333
330,Risedronate Sodium,[Na+].OC(CC1=CC=CN=C1)(P(O)(O)=O)P(O)([O-])=O,335.828125
331,Quinapril Hydrochloride,Cl.CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=C(C[C@H]1C(O)=O)C=CC=C2,13.5
332,Riluzole,NC1=NC2=CC=C(OC(F)(F)F)C=C2S1,6.84
333,Citalopram Hydrobromide,Br.CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,32.33333333
334,Tacrolimus,[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@H]1C(=O)O[C@@H]([C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@H]1CC[C@@H](O)[C@H](C1)OC,31.31926606
335,Tiotropium Bromide,[Br-].[H][C@]12O[C@@]1([H])[C@]1([H])C[C@H](C[C@@]2([H])[N+]1(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1,114.618
336,Minoxidil,NC1=CC(=NC(N)=N1=O)N1CCCCC1,1.525
337,Human Coagulation Factor X,n,30.47666667
338,"Antihemophilic Factor VIII Complex (Human, Monoclonal)",n,11.03102564
339,Padeliporfin,CCC1C(C)C2=CC3=C(C(C)=O)C(C)=C4C=C5C(C)C(CCC(O)=O)C6=[N]5[Pd++]5([N-]7C(=CC1=[N]25)C(C)=C(C(=O)NCCS(O)(=O)=O)C7=C6CC(=O)OC)[N-]34,1.197142857
340,Naxitamab,n,196.8
341,Fluciclovine F-18,N[C@]1(C[C@H]([18F])C1)C(O)=O,1.833
342,Alendronate Sodium,[Na+].NCCCC(O)(P(O)(O)=O)P(O)([O-])=O,94176
343,Risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,7.3
344,Thiopental Sodium,[Na+].CCCC(C)C1(CC)C(=O)NC([S-])=NC1=O,7.555666667
345,Turoctocog Alfa,n,9.775333333
346,Naltrexone,[H][C@@]12CC3=C4C(O[C@H]5C(=O)CC[C@]1(O)[C@@]45CCN2CC1CC1)=C(O)C=C3,5.7085
347,Ampicillin Sodium; Sulbactam Sodium,n,0.948888889
348,Darifenacin Hydrobromide,Br.NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,4.38
349,Hydroxocobalamin,[H][C@@]12[C@H](CC(N)=O)[C@@](C)(CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@@H](O)[C@H](O[C@@H]3CO)N3C=NC4=C3C=C(C)C(C)=C4)C3=C(C)C4=[N]5C(=CC6=[N]7C(=C(C)C8=[N]([C@]1(C)[C@@](C)(CC(N)=O)[C@@H]8CCC(N)=O)[Co+3]57([OH-])[N-]23)[C@@](C)(CC(N)=O)[C@@H]6CCC(N)=O)C(C)(C)[C@@H]4CCC(N)=O,26.25
350,Edotreotide,n,0.8
351,Agalsidase Alfa,n,1.64
352,Ferric Derisomaltose,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)OC[C@H]([C@H]([C@@H]([C@H](CO)O)O)O)O)O)O)O)O)O)O)O.[Fe+3],27
353,Fluorodopa F-18,N[C@@H](CC1=C([18F])C=C(O)C(O)=C1)C(O)=O,1
354,Ethinyl Estradiol; Norelgestromin,n,21.65
355,Lofexidine Hydrochloride,Cl.CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1,608.5
356,Oblimersen Sodium,n,2.2
357,Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP),n,95.91363636
358,Taliglucerase Alfa,n,0.417
359,Blinatumomab,n,2.109473684
360,Imipenem; Cilastatin Sodium,n,2.224941667
361,Daclizumab,n,399.9103448
362,Isepamycin,CN[C@@H]1[C@@H](O)[C@H](OC[C@]1(C)O)O[C@H]1[C@@H](C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]1O)NC(=O)[C@@H](O)CN,2.667142857
363,Sotalol Hydrochloride,Cl.CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,7.866666667
364,Finasteride,[H][C@@]12CC[C@@]3([H])[C@]4([H])CC[C@H](C(=O)NC(C)(C)C)[C@@]4(C)CC[C@]3([H])[C@@]1(C)C=CC(=O)N2,4.5
365,Bendamustine Hydrochloride,Cl.CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,0.667
366,Bromfenac Sodium,[Na+].NC1=C(C=CC=C1CC([O-])=O)C(=O)C1=CC=C(Br)C=C1,2.164285714
367,Tazarotene,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,6.22
368,Nimotuzumab,n,64.3
369,Aliskiren Hemifumarate,OC(=O)\C=C\C(O)=O.COCCCOC1=C(OC)C=CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)=C1,23.7
370,Cemiplimab,n,1022.818667
371,Propranolol Hydrochloride,Cl.CC(C)NCC(O)COC1=C2C=CC=CC2=CC=C1,3.963285714
372,Olaratumab,n,160.8
373,Atracurium Besylate,[O-]S(=O)(=O)C1=CC=CC=C1.COC1=CC2=C(C=C1OC)C(CC1=CC(OC)=C(OC)C=C1)[N+](C)(CCC(=O)OCCCCCOC(=O)CC[N+]1(C)CCC3=C(C=C(OC)C(OC)=C3)C1CC1=CC(OC)=C(OC)C=C1)CC2,0.334372727
374,Labetalol Hydrochloride,Cl.CC(CCC1=CC=CC=C1)NCC(O)C1=CC=C(O)C(=C1)C(N)=O,5.029166667
375,Ravulizumab,n,1063.569231
376,Treprostinil Sodium,[Na+].[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=C(C2)C(OCC([O-])=O)=CC=C1,0.634857143
377,Granisetron,CN1[C@H]2CCC[C@H]1C[C@H](C2)NC(=O)C1=NN(C)C2=C1C=CC=C2,5.805555556
378,Emtricitabine,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1,9.04
379,Nisoldipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1N(=O)=O)C(=O)OCC(C)C,6.4545
380,Selenious Acid,O[Se](O)=O,25
381,Ganciclovir,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1,3.476
382,Calcifediol,[H][C@@]1(CC[C@]2([H])[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C)[C@H](C)CCCC(C)(C)O,264
383,Secretin Synthetic Human,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CNC=N1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(N)=O,0.75
384,Fesoterodine Fumarate,OC(=O)\C=C\C(O)=O.CC(C)N(CC[C@H](C1=CC=CC=C1)C1=CC(CO)=CC=C1OC(=O)C(C)C)C(C)C,4
385,Lacosamide,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,12.62947368
386,Ceftriaxone Sodium; Lidocaine,n,4.45
387,Leflunomide,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,127.00285
388,Repaglinide,CCOC1=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(O)=O,0.87
389,Sumatriptan Succinate,OC(=O)CCC(O)=O.CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1,1.6
390,Idursulfase,n,1.814589286
391,Cefotaxime Sodium,[Na+].CO\N=C(C(=O)N[C@H]1[C@H]2SCC(COC(C)=O)=C(N2C1=O)C([O-])=O)\C1=CSC(N)=N1,2.2828
392,Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,2.060391304
393,Sugammadex Sodium,[Na+].O[C@H]1[C@@H](O)[C@@H]2O[C@H]3O[C@H](CSCCC([O-])=O)[C@@H](OC4O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]5O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]6O[C@H](CSCCC([O-])=O)C(O[C@H]7O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]8O[C@H](CSCCC([O-])=O)C(O[C@H]9O[C@H](CSCCC([O-])=O)[C@@H](OC1O[C@@H]2CSCCC([O-])=O)[C@H](O)[C@@H]9O)[C@H](O)[C@@H]8O)[C@H](O)[C@@H]7O)[C@H](O)[C@@H]6O)[C@H](O)[C@@H]5O)[C@H](O)[C@@H]4O)[C@H](O)[C@@H]3O,2.590379747
394,Selpercatinib,COC1=CC=C(CN2C3CC2CN(C3)C2=CC=C(C=N2)C2=CC(OCC(C)(C)O)=CN3N=CC(C#N)=C23)C=N1,16.9
395,Ceftaroline Fosamil,O.CC(O)=O.[H][C@]12SCC(SC3=NC(=CS3)C3=CC=[N+](C)C=C3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC)\C1=NSC(NP(O)(O)=O)=N1)C([O-])=O,1.699868421
396,Eprosartan Mesylate,CS(O)(=O)=O.CCCCC1=NC=C(N1CC1=CC=C(C=C1)C(O)=O)\C=C(/CC1=CC=CS1)C(O)=O,1.932121212
397,Aprotinin Bovine,n,7.601538462
398,Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(N2CCOCC2)C(F)=C1,4.216966292
399,Ganciclovir Sodium,[Na+].NC1=NC2=C(N=CN2COC(CO)CO)C([O-])=N1,3.35
400,Gadodiamide,CNC(=O)CN1CCN2CCN(CC(=O)NC)CC(=O)O[Gd](OC(=O)C2)OC(=O)C1,1.299727273
401,Reteplase,n,2.8535
402,Technetium Tc-99m Fanolesomab,n,2.866666667
403,Mecasermin Rinfabate Recombinant,n,10
404,Cefoperazone Sodium,[Na+].CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SCC(CSC4=NN=NN4C)=C(N3C2=O)C([O-])=O)C2=CC=C(O)C=C2)C(=O)C1=O,1.827935484
405,Fondaparinux Sodium,[Na+].CO[C@H]1O[C@H](COS([O-])(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS([O-])(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS([O-])(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS([O-])(=O)=O)[C@H](O)[C@H]4O)C([O-])=O)[C@H](OS([O-])(=O)=O)[C@H]3NS([O-])(=O)=O)[C@H](O)[C@H]2OS([O-])(=O)=O)C([O-])=O)[C@H](O)[C@H]1NS([O-])(=O)=O,15.924
406,Etanercept,n,71.91666667
407,Epoetin Zeta,n,5.25
408,Sodium Ferric Gluconate,[Na+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O[Fe](OC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)OC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,1.25625
409,Cefiderocol Sulfate Tosylate,OS(O)(=O)=O.CC1=CC=C(C=C1)S(O)(=O)=O.[H][C@]12SCC(C[N+]3(CCCC3)CCNC(=O)C3=CC=C(O)C(O)=C3Cl)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC(N)=N1)C([O-])=O,2.47
410,Methylnaltrexone Bromide,[Br-].C[N+]1(CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@]2(O)CCC4=O)=C35)CC1CC1,6.333333333
411,Bortezomib,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,45.72926316
412,Iohexol,CC(=O)N(CC(O)CO)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I,15.29506667
413,Encainide,COC1=CC=C(C=C1)C(=O)NC1=CC=CC=C1CCC1CCCCN1C,2.883333333
414,Amsacrine,COC1=CC(NS(C)(=O)=O)=CC=C1NC1=C2C=CC=CC2=NC2=C1C=CC=C2,4.7
415,Carmustine,ClCCNC(=O)N(CCCl)N=O,0.3165
416,Pentetate Calcium Trisodium,[Na+].[Ca++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O,0.611666667
417,Ibritumomab Tiuxetan,n,33.092
418,Dihydroergotamine Mesylate,CS(O)(=O)=O.[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@H](CN2C)C(=O)N[C@]1(C)O[C@]2(O)N([C@@H](CC3=CC=CC=C3)C(=O)N3CCC[C@@]23[H])C1=O,9.866666667
419,Bupivacaine,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,3.75
420,"Sodium Fluoride, F-18",[18F-].[Na+],1.5
421,Betrixaban,OC(=O)\C=C/C(O)=O.COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC1=CC=C(Cl)C=N1,40
422,"Gonadotropin, Chorionic",n,18.69230769
423,Bezlotoxumab,n,510.2690244
424,Emapalumab,n,300
425,Imlifidase,n,80.8
426,Etoposide Phosphate,[H][C@@]12CO[C@@H](C)O[C@@]1([H])[C@H](O)[C@@H](O)[C@H](O[C@@H]1C3=C(C=C4OCOC4=C3)[C@@H](C3=CC(OC)=C(OP(O)(O)=O)C(OC)=C3)[C@@]3([H])C(=O)OC[C@]13[H])O2,6.568795181
427,Risankizumab,n,309.9538462
428,Ceforanide,NCC1=CC=CC=C1CC(=O)N[C@H]1[C@H]2SCC(CSC3=NN=NN3CC(O)=O)=C(N2C1=O)C(O)=O,2.75575
429,Cerivastatin Sodium,[Na+].COCC1=C(N=C(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1)C(C)C,1.79
430,Aducanumab,n,595.2
431,Milnacipran Hydrochloride,Cl.CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C1=CC=CC=C1,8.85
432,Human Hepatitis B Immunoglobulin,n,534.72
433,Brentuximab Vedotin,n,105.5224242
434,Tropisetron,CN1[C@H]2CC[C@@H]1C[C@H](C2)OC(=O)C1=CNC2=C1C=CC=C2,5.6
435,Piperacillin Sodium; Tazobactam Sodium,n,1.02099262
436,Eletriptan Hydrobromide,Br.CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,3.971428571
437,Hydrocortisone,[H][C@@]12CCC3=CC(=O)CC[C@]3(C)[C@@]1([H])[C@@H](O)C[C@@]1(C)[C@@]2([H])CC[C@]1(O)C(=O)CO,1.558
438,Liraglutide,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CN=CN1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)C(O)=O,8.066666667
439,Levosulpiride,CCN1CCC[C@H]1CNC(=O)C1=CC(=CC=C1OC)S(N)(=O)=O,7.4
440,Simvastatin,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,1.9
441,Insulin Detemir (rDNA Origin),n,1.92
442,Isradipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C,3.3
443,Naloxone Hydrochloride,Cl.[H][C@@]12CC3=C4C(O[C@H]5C(=O)CC[C@]1(O)[C@@]45CCN2CC=C)=C(O)C=C3,1.222
444,Tiludronate Disodium,[Na+].OP([O-])(=O)C(SC1=CC=C(Cl)C=C1)P(O)([O-])=O,52.46833333
445,Trazodone Hydrochloride,Cl.ClC1=CC(=CC=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1,7.3
446,Caffeine Citrate,OC(=O)CC(O)(CC(O)=O)C(O)=O.CN1C=NC2=C1C(=O)N(C)C(=O)N2C,6.7
447,Valdecoxib,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C1=CC=CC=C1,7.336666667
448,Iloprost,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O,0.25825
449,Mercaptopurine,S=C1NC=NC2=C1NC=N2,0.799833333
450,Fingolimod Hydrochloride,Cl.CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1,144
451,Amoxicillin; Clavulanate Potassium,n,1.97
452,Gadoxetate Disodium,[Na+].CCOC1=CC=C(C[C@H]2C[N]34CC[N]56CC(=O)O[Gd]3535(OC(=O)C4)(OC(=O)C6)OC(=O)C[N]23CC(=O)O5)C=C1,1.427741935
453,Iotrolan,CN(C(=O)CC(=O)N(C)C1=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C1I)C1=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C1I,1.765714286
454,Iopamidol,C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I,2
455,Cefpiramide Sodium,[Na+].CN1N=NN=C1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](NC(=O)C1=C(O)C=C(C)N=C1)C1=CC=C(O)C=C1)C2=O)C([O-])=O,5.355591398
456,"Plasminogen, Human",n,35.34705882
457,Vancomycin Hydrochloride,Cl.CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@H]1C(=O)N[C@@H]([C@H](O)C3=CC(Cl)=C(O4)C=C3)C(=O)N[C@H](C(O)=O)C3=C(C(O)=CC(O)=C3)C3=C(O)C=CC1=C3)C(Cl)=C2,11.11434615
458,Pixantrone Dimaleate,OC(=O)\C=C/C(O)=O.NCCNC1=CC=C(NCCN)C2=C1C(=O)C1=CC=NC=C1C2=O,17.53333333
459,Cefuroxime Sodium,[Na+].[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C([O-])=O,1.189
460,Indium In-111 Pentetreotide,C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)C[N+]2(CC[N+]34CC[N+]56CC(=O)O[111In]235(OC(=O)C4)OC(=O)C6)CC(O)=O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,6
461,Idarucizumab,n,4.7499
462,Casimersen,n,3.5
463,Mesalamine,NC1=CC(C(O)=O)=C(O)C=C1,0.7
464,Amifostine,NCCCNCCSP(O)(O)=O,0.126792308
465,Reslizumab,n,426.83
466,Vinorelbine Tartrate,O[C@H]([C@@H](O)C(O)=O)C(O)=O.[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@H]2C[N@@](CCC3=C1NC1=CC=CC=C31)C(CC)=C2)C(=O)OC,21.58910891
467,Gadobenate Dimeglumine,CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN1CCN2CCN(CC(=O)O[Gd](OC(=O)C2)OC(=O)C1)C(COCC1=CC=CC=C1)C(O)=O,2.799174528
468,Fosaprepitant Dimeglumine,CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C[C@@H](O[C@H]1OCCN(CC2=NC(=O)N(N2)P(O)(O)=O)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,8.389583333
469,Trabectedin,[H][C@@]12CC3=C(C(O)=C(OC)C(C)=C3)[C@@]([H])(N1C)[C@]1([H])[C@@H]3SC[C@]4(NCCC5=CC(O)=C(OC)C=C45)C(=O)OC[C@H](N1[C@H]2O)C1=C3C(OC(C)=O)=C(C)C2=C1OCO2,67.09
470,Atoltivimab; Odesivimab; Maftivimab,n,562.05
471,Insulin Degludec,n,5
472,Eteplirsen,n,2.854964286
473,Porfimer Sodium,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)O)C)C(=C4C)C(C)OC(C)C6=C(C7=CC8=C(C(=C(N8)C=C9C(=C(C(=N9)C=C1C(=C(C(=N1)C=C6N7)C)CCC(=O)O)CCC(=O)O)C)C)C(C)O)C)C(=C3CCC(=O)O)C)CCC(=O)O,411.6583333
474,Pentamidine Isethionate,OCCS(O)(=O)=O.NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,6.4
475,Atenolol,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,5.699727273
476,Crizanlizumab,n,216.0571429
477,Vardenafil Hydrochloride,Cl.CCCC1=NC(C)=C2N1NC(=NC2=O)C1=C(OCC)C=CC(=C1)S(=O)(=O)N1CCN(CC)CC1,3.8
478,Daunorubicin Hydrochloride,Cl.COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,8.266
479,Albuterol,CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1,4.43
480,Human Coagulation Factor IX (Recombinant),n,46.98861111
481,Alteplase,n,0.6885
482,Pegaspargase,n,253.8818182
483,Esmolol Hydrochloride,Cl.COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,0.132744444
484,Golimumab,n,313.508
485,Amphotericin B; Cholesteryl Sulfate,n,150.95
486,Lisinopril,[H][C@]1(CCCN1C(=O)[C@H](CCCCN)N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(O)=O,42.47142857
487,Epoprostenol Sodium,[Na+].CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2O\C(C[C@H]12)=C/CCCC([O-])=O,0.00825
488,Clinafloxacin,NC1CCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O,5.706
489,Pralatrexate,NC1=NC(N)=C2N=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=NC2=N1,12
490,Vinblastine Sulfate,OS(O)(=O)=O.[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@H]2C[N@](CCC3=C1NC1=CC=CC=C31)C[C@](O)(CC)C2)C(=O)OC,11.5
491,Cefotetan Disodium,[Na+].CO[C@]1(NC(=O)C2S\C(S2)=C(\C(N)=O)C([O-])=O)[C@H]2SCC(CSC3=NN=NN3C)=C(N2C1=O)C([O-])=O,3.624545455
492,Etonogestrel,[H][C@]12CCC(=O)C=C1CC[C@@]1([H])[C@]3([H])CC[C@@](O)(C#C)[C@@]3(CC)CC(=C)[C@]21[H],24.52
493,Levorphanol Tartrate,O[C@H]([C@@H](O)C(O)=O)C(O)=O.[H][C@@]12CCCC[C@@]11CCN(C)[C@@H]2CC2=C1C=C(O)C=C2,11
494,Itraconazole,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=NC=N3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1,31.89642857
495,Alizapride,COC1=C(C=C2N=NNC2=C1)C(=O)NCC1CCCN1CC=C,2.75
496,Sitafloxacin,N[C@@H]1CN(CC11CC1)C1=C(Cl)C2=C(C=C1F)C(=O)C(=CN2[C@@H]1C[C@@H]1F)C(O)=O,6.586666667
497,Nadolol,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@@H](O)[C@@H](O)C2,9.205
498,Secretin Synthetic Porcine,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CNC=N1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(N)=O,0.26489375
499,Pentosan Polysulfate Sodium,COC1COC(C(C1OS(=O)(=O)[O-])OS(=O)(=O)[O-])OC2COC(C(C2OS(=O)(=O)[O-])OS(=O)(=O)[O-])OC3COC(C(C3OS(=O)(=O)[O-])OC4C(C(C(C(O4)C(=O)[O-])OC)OS(=O)(=O)[O-])OS(=O)(=O)[O-])OC5COC(C(C5OS(=O)(=O)[O-])OS(=O)(=O)[O-])OC.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],15.249
500,Cloxacillin Sodium,[Na+].CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C([O-])=O)C(=NO1)C1=CC=CC=C1Cl,1.467875
501,Isosorbide Dinitrate,[H][C@]12OC[C@H](ON(=O)=O)[C@@]1([H])OC[C@H]2ON(=O)=O,0.390444444
502,Technetium Tc-99m Sestamibi Kit,COC(C)(C)C[N+]#[C-][99Tc]([C-]#[N+]CC(C)(C)OC)([C-]#[N+]CC(C)(C)OC)([C-]#[N+]CC(C)(C)OC)([C-]#[N+]CC(C)(C)OC)[C-]#[N+]CC(C)(C)OC,3.46
503,Temoporfin,OC1=CC(=CC=C1)C1=C2\CC/C(N2)=C(C2=CC(O)=CC=C2)/C2=N/C(/C=C2)=C(\C2=CC=C(N2)\C(C2=CC(O)=CC=C2)=C2/C=CC\1=N/2)C1=CC=CC(O)=C1,60.125
504,Emicizumab,n,656.4
505,Dofetilide,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,8.339130435
506,Perflutren,FC(F)(F)C(F)(F)C(F)(F)F,0.025333333
507,Lidocaine; Tetracaine,n,2
508,"Somatropin, Biosynthetic",n,0.360628743
509,Colistin Sulfate,n,5.075
510,Antithrombin Alfa,n,6.744285714
511,Gonadorelin Acetate,CC(O)=O.CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,0.1
512,Esketamine Hydrochloride,Cl.CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl,10.7
513,Meperidine Hydrochloride,Cl.CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1,5.375
514,Pramipexole Dihydrochloride,Cl.CCCN[C@H]1CCC2=C(C1)SC(N)=N2,9.26
515,Somatrem,n,0.367
516,Nevirapine,CC1=CC=NC2=C1NC(=O)C1=C(N=CC=C1)N2C1CC1,48.93666667
517,Decitabine,NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1,0.526851852
518,Chlortetracycline Hydrochloride,Cl.[H][C@@]12CC3C(C(=O)C4=C(C(Cl)=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,17.075
519,Parathyroid Hormone,n,1.2746
520,Omeprazole,COC1=CC=C2NC(=NC2=C1)S(=O)CC1=NC=C(C)C(OC)=C1C,0.711870968
521,Vorapaxar Sulfate,OS(O)(=O)=O.[H][C@@]12C[C@@H](CC[C@@]1([H])[C@H](\C=C\C1=CC=C(C=N1)C1=CC=CC(F)=C1)[C@]1([H])[C@@H](C)OC(=O)[C@]1([H])C2)NC(=O)OCC,159
522,Amiodarone Hydrochloride,Cl.CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=CC=CC=C2O1,428.212
523,Clomethiazole,CC1=C(CCCl)SC=N1,9.325
524,Ferric Carboxymaltose,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]([C@@H](CO)O)[C@H]([C@@H](C(=O)[O-])O)O)CO)CO)O)O)O)O.O.[OH-].[O-2].[Fe+3],9.814285714
525,Pertuzumab,n,378.0512821
526,Fleroxacin,CN1CCN(CC1)C1=C(F)C2=C(C=C1F)C(=O)C(=CN2CCF)C(O)=O,8.6
527,Foscarnet Sodium,[Na+].[O-]C(=O)P([O-])([O-])=O,6.706923077
528,Denileukin Diftitox,n,1.047
529,Diphenhydramine Hydrochloride,Cl.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,7.1
530,Desmopressin Acetate,CC(O)=O.NC(=N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,4.285815789
531,Chlorpromazine Hydrochloride,Cl.CN(C)CCCN1C2=CC(Cl)=CC=C2SC2=C1C=CC=C2,11.1
532,Dalbavancin Hydrochloride,CC(C)CCCCCCCCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)[C@H]([C@H]6C(=O)N[C@@H](C7=C(C(=CC(=C7)O)O[C@@H]8[C@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)C9=C(C=CC(=C9)[C@H](C(=O)N6)NC(=O)[C@@H]4NC(=O)[C@@H]1C2=C(C(=CC(=C2)OC2=C(C=CC(=C2)[C@H](C(=O)N[C@H](CC2=CC=C(O3)C=C2)C(=O)N1)NC)O)O)Cl)O)C(=O)NCCCN(C)C)O)Cl)C(=O)O)O)O.Cl,254.7043478
533,Doripenem,[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,1.058522535
534,Artesunate,[H][C@@]12CC[C@@]3(C)OO[C@@]11[C@@]([H])(CC[C@H]2C)[C@@H](C)[C@@H](OC(=O)CCC(O)=O)O[C@]1([H])O3,0.158483333
535,Maraviroc,[H][C@]12CC[C@]([H])(C[C@H](C1)N1C(C)=NN=C1C(C)C)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)C1=CC=CC=C1,13.17142857
536,Guanfacine Hydrochloride,Cl.NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,12.83333333
537,Beclomethasone Dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,0.5
538,Arbekacin,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,26.485
539,Edaravone,CC1=NN(C(=O)C1)C1=CC=CC=C1,4.582466667
540,Gliclazide,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1,16.4
541,Lutetium Dotatate Lu-177,[H][C@]1(NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C[N]12CC[N]34CC[N]56CC[N]7(CC1)CC(=O)O[177Lu]2357(OC(=O)C4)OC(=O)C6)[C@@H](C)O,45.85585
542,Metreleptin,n,3.374
543,Mibefradil,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C,12.18965517
544,Propafenone Hydrochloride,Cl.CCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,7.5625
545,Nalbuphine Hydrochloride,Cl.O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,1.522958333
546,Canagliflozin,O.CC1=C(CC2=CC=C(S2)C2=CC=C(F)C=C2)C=C(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,9.51
547,Iobenguane Sulfate I-123,OS(O)(=O)=O.NC(=N)NCC1=CC([123I])=CC=C1,9
548,Thiotepa,S=P(N1CC1)(N1CC1)N1CC1,1.821518519
549,Obinutuzumab,n,714.6
550,Rivaroxaban,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,4.5
551,Abatacept,n,345.7811321
552,Ipilimumab,n,355.0575758
553,Factor XIII Concentrate (Human),n,304.2543243
554,Vancomycin,[H][C@]12NC(=O)[C@]([H])(NC(=O)[C@]3([H])NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC)[C@H](O)C4=CC(Cl)=C(OC5=C(O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O[C@H]6C[C@](C)(N)[C@H](O)[C@H](C)O6)C(OC6=C(Cl)C=C(C=C6)[C@H]1O)=CC3=C5)C=C4)C1=CC(=C(O)C=C1)C1=C(C=C(O)C=C1O)[C@H](NC2=O)C(O)=O,92
555,Stavudine,CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O,1.1305
556,Methoxy Polyethylene Glycol-Epoetin Beta,n,98.77627119
557,Dichloroacetic Acid,OC(=O)C(Cl)Cl,0.755
558,Nofetumomab,n,6
559,Cisplatin,[NH3][Pt]([NH3])(Cl)Cl,21.46636364
560,Ibuprofen Lysine,NCCCC[C@H](N)C(O)=O.CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,54.14285714
561,Oprelvekin,n,1.75
562,Flucloxacillin,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl)C(O)=O,2.8775
563,Golodirsen,n,3.46
564,Diltiazem Hydrochloride,Cl.COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,7.879267176
565,Pancuronium Bromide,[Br-].[H][C@@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@@H](OC(C)=O)[C@H](C[C@@]34[H])[N+]3(C)CCCCC3)[C@@]1(C)C[C@@H]([C@H](C2)OC(C)=O)[N+]1(C)CCCCC1,1.48
566,Cisatracurium Besylate,OS(=O)(=O)C1=CC=CC=C1.COC1=C(OC)C=C(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C=C2)C=C1,0.462814815
567,Margetuximab,n,470.4
568,Ceftobiprole Medocaril,[H][C@]12SCC(\C=C3/CCN([C@@H]4CCN(C4)C(=O)OCC4=C(C)OC(=O)O4)C3=O)=C(N1C(=O)[C@H]2NC(=O)C(=NO)C1=NSC(N)=N1)C(O)=O,3
569,Galantamine Hydrobromide,Br.COC1=CC=C2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3OC1=C24,7.4
570,Glutamine,N[C@@H](CCC(N)=O)C(O)=O,1.051428571
571,Pamidronate Disodium,[Na+].NCCC(O)(P(O)([O-])=O)P(O)([O-])=O,28
572,Cefmetazole Sodium,[Na+].CO[C@]1(NC(=O)CSCC#N)[C@H]2SCC(CSC3=NN=NN3C)=C(N2C1=O)C([O-])=O,1.255384615
573,Demeclocycline Hydrochloride,Cl.[H][C@]12C[C@@]3([H])[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C(=O)C1=C([C@H]2O)C(Cl)=CC=C1O,23.6375
574,Nimodipine,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OC(C)C,2.11
575,"Urea, C-13",N[13C](N)=O,16.75
576,Cefamandole Nafate,[Na+].[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@H]2NC(=O)[C@H](OC=O)C1=CC=CC=C1)C([O-])=O,0.288714286
577,Ioxilan,CC(=O)N(CC(O)CO)C1=C(I)C(C(=O)NCCO)=C(I)C(C(=O)NCC(O)CO)=C1I,1.126875
578,Cosyntropin,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(O)=O,0.575
579,Cyclophosphamide,ClCCN(CCCl)P1(=O)NCCCO1,4.95125
580,Buflomedil,COC1=CC(OC)=C(C(=O)CCCN2CCCC2)C(OC)=C1,3.25
581,Epoetin Theta,n,5.233333333
582,Siltuximab,n,448.5166667
583,Tagraxofusp,n,0.936047619
584,Chlorthalidone,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=C1C=CC=C2,28.6
585,Cetuximab,n,78.30441558
586,Colistimethate Sodium,[Na+].CCC(C)CCCCC(=O)N[C@@H](CCNCS([O-])(=O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCNCS([O-])(=O)=O)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCNCS([O-])(=O)=O)NC(=O)[C@H](CCNCS([O-])(=O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCNCS([O-])(=O)=O)NC1=O)[C@@H](C)O,3.545384615
587,Moexipril Hydrochloride,Cl.CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC(OC)=C(OC)C=C2C[C@H]1C(O)=O,1.238833333
588,Ondansetron,CN1C2=C(C(=O)C(CC2)CN2C=CN=C2C)C2=C1C=CC=C2,5.166153846
589,Nifedipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1N(=O)=O)C(=O)OC,1.8275
590,Triptorelin Pamoate,OC(=O)C1=C(O)C(CC2=C3C=CC=CC3=CC(C(O)=O)=C2O)=C2C=CC=CC2=C1.CC(C)C[C@H](NC(=O)C(CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,1.683529412
591,Indocyanine Green,[Na+].CC1(C)\C(N(CCCCS([O-])(=O)=O)C2=C1C1=CC=CC=C1C=C2)=C/C=C\C=C\C=C\C1=[N+](CCCCS([O-])(=O)=O)C2=C(C3=CC=CC=C3C=C2)C1(C)C,0.056833333
592,Fentanyl Hydrochloride,Cl.CCC(=O)N(C1CCN(CC1)CCC1=CC=CC=C1)C1=CC=CC=C1,8.4515
593,Human Coagulation Factor VIII (Recombinant),n,12.69764542
594,Ticarcillin Disodium,[Na+].[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C([O-])=O)C1=CSC=C1)C([O-])=O,1.747125
595,Gefitinib,COC1=CC2=C(C=C1OCCCN1CCOCC1)C(NC1=CC(Cl)=C(F)C=C1)=NC=N2,44.45555556
596,Leucovorin Calcium,[Ca++].NC1=NC2=C(N(C=O)C(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)CN2)C(O)=N1,6.2
597,"Antihemophilic Factor (Recombinant), Single Chain",n,12.3125
598,Oritavancin Diphosphate,OP(O)(O)=O.[H][C@@]1(C[C@](C)(NCC2=CC=C(C=C2)C2=CC=C(Cl)C=C2)[C@@H](O)[C@H](C)O1)O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2OC3=CC=C(C=C3Cl)[C@@H](O)[C@@]([H])(NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@]([H])(CC(N)=O)C(=O)N[C@@]3([H])C(=O)N[C@@]4([H])C(=O)NC(C(=O)N[C@H](C(O)=O)C5=CC(O)=CC(O)=C5C5=C(O)C=CC4=C5)[C@]([H])(O[C@H]4C[C@](C)(N)[C@@H](O)[C@H](C)O4)C4=CC(Cl)=C(OC1=CC3=C2)C=C4,213.7809333
599,Dinoprostone,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,0.017
600,Dexmethylphenidate Hydrochloride,Cl.COC(=O)[C@@H]([C@H]1CCCCN1)C1=CC=CC=C1,2.5
601,Insulin Glulisine,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC,0.217
602,Ioxaglate Meglumine; Ioxaglate Sodium,CC(=O)N(C)C1=C(C(=C(C(=C1I)C(=O)NCC(=O)NC2=C(C(=C(C(=C2I)C(=O)O)I)C(=O)NCCO)I)I)C(=O)NC)I.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,1.6
603,Nonacog Beta Pegol,n,86.45289474
604,Pipecuronium Bromide,[Br-].[H][C@@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@@H](OC(C)=O)[C@H](C[C@@]34[H])N3CC[N+](C)(C)CC3)[C@@]1(C)C[C@@H]([C@H](C2)OC(C)=O)N1CC[N+](C)(C)CC1,3.333
605,Tolfenamic Acid,CC1=C(Cl)C=CC=C1NC1=CC=CC=C1C(O)=O,2.15
606,Panitumumab,n,137.2323529
607,Memantine Hydrochloride,Cl.[H][C@]12C[C@]3(C)C[C@](C)(C1)C[C@](N)(C2)C3,60.42222222
608,Metoprolol Tartrate,O[C@H]([C@@H](O)C(O)=O)C(O)=O.COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,0.2
609,Gentamicin Sulfate,OS(O)(=O)=O.CN[C@@H]1[C@@H](O)[C@H](OC[C@]1(C)O)O[C@H]1[C@H](N)C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)CC[C@H]2N)[C@@H]1O.CN[C@@H]1[C@@H](O)[C@H](OC[C@]1(C)O)O[C@H]1[C@H](N)C[C@H](N)[C@@H](O[C@H]2O[C@@H](CC[C@H]2N)[C@@H](C)N)[C@@H]1O.CN[C@H](C)[C@@H]1CC[C@@H](N)[C@H](O1)O[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O[C@H]2OC[C@](C)(O)[C@H](NC)[C@H]2O)[C@H]1O,4.045
610,Amdinocillin,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2\N=C\N1CCCCCC1)C(O)=O,2.082042857
611,Alcuronium,[H][C@]12C[C@@]3([H])[C@@]4(CC[N@@+]3(CC=C)C\C1=C/CO)C1=CC=CC=C1N1\C=C3\[C@@]5([H])C[C@@]6([H])[C@@]7(CC[N@@+]6(CC=C)C\C5=C/CO)C5=CC=CC=C5N(\C=C2/[C@@]41[H])[C@@]37[H],2.9052
612,Edrophonium Chloride,[Cl-].CC[N+](C)(C)C1=CC=CC(O)=C1,1.833
613,Miconazole,ClC1=CC=C(COC(CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C(Cl)=C1,13.1
614,Atezolizumab,n,559.6153846
615,Ibutilide Fumarate,OC(=O)\C=C\C(O)=O.CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,5.466153846
616,Sulfur Hexafluoride,FS(F)(F)(F)(F)F,0.130783333
617,Xamoterol,OC(CNCCNC(=O)N1CCOCC1)COC1=CC=C(O)C=C1,7.7
618,Rocuronium Bromide,[Br-].[H][C@@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@@H](OC(C)=O)[C@H](C[C@@]34[H])[N+]3(CCCC3)CC=C)[C@@]1(C)C[C@@H]([C@@H](O)C2)N1CCOCC1,1.178720606
619,Cladribine,NC1=NC(Cl)=NC2=C1N=CN2[C@@H]1C[C@H](O)[C@@H](CO)O1,13.31166667
620,Degarelix Acetate,O.CC(O)=O.CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=C(NC(N)=O)C=C1)NC(=O)[C@H](CC1=CC=C(NC(=O)[C@@H]2CC(=O)NC(=O)N2)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,14.775
621,Ceftazidime,[H][C@]12SCC(C[N+]3=CC=CC=C3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC(N)=N1)C([O-])=O,1.758909091
622,Ferumoxytol,n,14.36344828
623,Alogliptin Benzoate,OC(=O)C1=CC=CC=C1.CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=C(C=CC=C2)C#N)C1=O,20.88
624,Rapacuronium Bromide,[Br-].[H][C@@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@@H](OC(=O)CC)[C@H](C[C@@]34[H])[N+]3(CCCCC3)CC=C)[C@@]1(C)C[C@@H]([C@H](C2)OC(C)=O)N1CCCCC1,2.840831169
625,Fostemsavir Tromethamine,NC(CO)(CO)CO.COC1=CN=C(N2C=NC(C)=N2)C2=C1C(=CN2COP(O)(O)=O)C(=O)C(=O)N1CCN(CC1)C(=O)C1=CC=CC=C1,11
626,Cefoxitin Sodium,[Na+].CO[C@]1(NC(=O)CC2=CC=CS2)[C@H]2SCC(COC(N)=O)=C(N2C1=O)C([O-])=O,0.962
627,Hydroxychloroquine Sulfate,OS(O)(=O)=O.CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,1146.461538
628,Lepirudin (rDNA),n,1.471372549
629,Belimumab,n,329.0086486
630,"Bazedoxifene Acetate; Estrogens, Conjugated",n,23.5
631,Candesartan Cilexetil,CCOC1=NC2=CC=CC(C(=O)OC(C)OC(=O)OC3CCCCC3)=C2N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1,9.702
632,Levetiracetam,CC[C@H](N1CCCC1=O)C(N)=O,7.482576923
633,Sulesomab,n,1.5
634,Tolcapone,CC1=CC=C(C=C1)C(=O)C1=CC(O)=C(O)C(=C1)N(=O)=O,1.22
635,Rizatriptan Benzoate,OC(=O)C1=CC=CC=C1.CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2,2.042168675
636,Oxytetracycline Hydrochloride,Cl.[H][C@]12[C@H](O)[C@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@]3(C)O)=C(O)[C@@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H]2N(C)C,18.66666667
637,Dezocine,[H][C@@]12CCCCC[C@@](C)([C@H]1N)C1=C(C2)C=CC(O)=C1,2.464615385
638,Nateglinide,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,1.73625
639,Pyrimethamine,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1,140
640,Flosequinan,CN1C=C(C(=O)C2=C1C=C(F)C=C2)S(C)=O,1.761
641,Asenapine Maleate,OC(=O)\C=C/C(O)=O.[H][C@]12CN(C)C[C@]1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1,24
642,Tiagabine Hydrochloride,Cl.CC1=C(SC=C1)/C(=C/CCN1CCC[C@H](C1)C(O)=O)/C1=C(C)C=CS1,7.2625
643,Miglitol,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,1.546
644,Ibalizumab,n,43.61153846
645,Leuprolide Mesylate,CS(O)(=O)=O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,3
646,Prochlorperazine,CN1CCN(CCCN2C3=CC(Cl)=CC=C3SC3=C2C=CC=C3)CC1,15.8
647,Sitagliptin Phosphate,O.OP(O)(O)=O.N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=C(F)C=C(F)C(F)=C1,11.375
648,Caspofungin Acetate,CC(O)=O.CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN,10.39172414
649,Sacituzumab Govitecan,n,58.66666667
650,Ocriplasmin,n,3.5
651,Epoetin Alfa,n,4.902622951
652,Fosfomycin Tromethamine,C[C@@H]1O[C@@H]1P(O)(O)=O.NC(CO)(CO)CO,2.204285714
653,Ocrelizumab,n,532.44
654,Piflufolastat F-18,OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)C1=CC=C([18F])N=C1)C(O)=O)C(O)=O,1.82
655,Plicamycin,[H][C@]1(CC2=C(C(=O)[C@H]1O[C@H]1C[C@@H](O[C@H]3C[C@@H](O[C@H]4C[C@](C)(O)[C@H](O)[C@@H](C)O4)[C@@H](O)[C@@H](C)O3)[C@H](O)[C@@H](C)O1)C(O)=C1C(C=C(O[C@H]3C[C@@H](O[C@H]4C[C@@H](O)[C@H](O)[C@@H](C)O4)[C@H](O)[C@@H](C)O3)C(C)=C1O)=C2)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O,9.8
656,Telavancin Hydrochloride,Cl.CCCCCCCCCCNCCN[C@@]1(C)C[C@@H](O[C@@H](C)[C@H]1O)O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2OC3=C(Cl)C=C(C=C3)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]4C(=O)N[C@@H]([C@H](O)C5=CC=C(OC1=CC3=C2)C(Cl)=C5)C(=O)N[C@H](C(O)=O)C1=C(C(O)=C(CNCP(O)(O)=O)C(O)=C1)C1=C(O)C=CC4=C1,8.030536913
657,Vedolizumab,n,404.7854545
658,Tranexamic Acid,NC[C@H]1CC[C@@H](CC1)C(O)=O,5.466
659,Acalabrutinib,CC#CC(=O)N1CCC[C@H]1C1=NC(C2=CC=C(C=C2)C(=O)NC2=NC=CC=C2)=C2N1C=CN=C2N,1.78
660,Epinastine Hydrochloride,Cl.NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21,7.80675
661,Evinacumab,n,600
662,Ferumoxides,n,2
663,Recombinant Human C1 Inhibitor,n,31.35384615
664,Saquinavir Mesylate,CS(O)(=O)=O.[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)C1=CC=C3C=CC=CC3=N1)[C@@H](C2)C(=O)NC(C)(C)C,7.655
665,Bamlanivimab,n,422.4
666,Sildenafil Citrate,OC(=O)CC(O)(CC(O)=O)C(O)=O.CCCC1=NN(C)C2=C1NC(=NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1,3.425263158
667,Mecasermin Recombinant,n,0.5
668,Cefonicid Sodium,[Na+].O[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSC3=NN=NN3CS([O-])(=O)=O)=C(N2C1=O)C([O-])=O)C1=CC=CC=C1,8.6025
669,Insulin Lispro; Insulin Lispro Protamine,n,0.65
670,Raltitrexed,CN(CC1=CC2=C(NC(C)=NC2=O)C=C1)C1=CC=C(S1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,0.8266
671,Lithium Carbonate,[Li+].[O-]C([O-])=O,7.8
672,Cibenzoline,C1CN=C(N1)C1CC1(C1=CC=CC=C1)C1=CC=CC=C1,14.85
673,Acyclovir,NC1=NC2=C(N=CN2COCCO)C(=O)N1,2.33
674,Technetium Tc-99m Red Blood Cell Kit,n,48.18888889
675,Delafloxacin,CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.NC1=C(F)C=C(F)C(=N1)N1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CC(O)C3)C(Cl)=C12,8.836363636
676,Argatroban,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=C2NCC(C)CC2=CC=C1,0.851294118
677,Fentanyl Citrate,OC(=O)CC(O)(CC(O)=O)C(O)=O.CCC(=O)N(C1CCN(CC1)CCC1=CC=CC=C1)C1=CC=CC=C1,4.467277778
678,Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,39.16291667
679,Naproxen,COC1=CC2=CC=C(C=C2C=C1)[C@H](C)C(O)=O,11
680,Alemtuzumab,n,76.74863636
681,Patisiran Sodium,n,62.53333333
682,Meptazinol,CCC1(CCCCN(C)C1)C1=CC(O)=CC=C1,2.05
683,Brexpiprazole,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,64.9
684,Pyridostigmine Bromide,[Br-].CN(C)C(=O)OC1=C[N+](C)=CC=C1,3.2
685,Fluconazole,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=CC=C(F)C=C1F,16.75581395
686,Polidocanol,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,1.26571375
687,Amitriptyline Hydrochloride,Cl.CN(C)CC\C=C1\C2=C(CCC3=C1C=CC=C3)C=CC=C2,18.95
688,Progesterone,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O,0.083
689,Vonicog Alfa,n,17.80636364
690,Doxifluridine,C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=C(F)C(=O)NC1=O,0.35
691,Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,6.983636364
692,Baricitinib,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,4.08
693,Amlodipine Besylate,OS(=O)(=O)C1=CC=CC=C1.CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,42.28055556
694,Carfilzomib,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,0.652458333
695,Dexamethasone,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,3.025
696,Etidronate Disodium,[Na+].CC(O)(P(O)([O-])=O)P(O)([O-])=O,6
697,Immune Globulin (Human),n,484.5131967
698,Brivaracetam,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1,9.061818182
699,Abemaciclib,CCN1CCN(CC1)CC1=CC=C(NC2=NC=C(F)C(=N2)C2=CC3=C(N=C(C)N3C(C)C)C(F)=C2)N=C1,18.3
700,Paricalcitol,[H][C@@]1(CC[C@]2([H])[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1)[C@H](C)\C=C\[C@H](C)C(C)(C)O,11.20747664
701,Dapagliflozin Propanediol,CC(O)CO.CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1,12.2
702,Atropine; Pralidoxime Chloride,n,6.5
703,"Thallous Chloride, Tl-201",Cl[201Tl],105.6332
704,Bethanidine Sulfate,OS(O)(=O)=O.CN\C(NCC1=CC=CC=C1)=N/C,11.7
705,Clonidine,ClC1=CC=CC(Cl)=C1NC1=NCCN1,9.666666667
706,Gabapentin,NCC1(CCCCC1)CC(O)=O,5.466666667
707,Technetium Tc-99m Sodium Pertechnetate Generator,n,4.190571429
708,Topotecan Hydrochloride,Cl.CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC(O)=C(CN(C)C)C1=C3)C2=O,2.85704918
709,Melphalan Flufenamide Hydrochloride,Cl.CCOC(=O)[C@H](CC1=CC=C(F)C=C1)NC(=O)[C@@H](N)CC1=CC=C(C=C1)N(CCCl)CCCl,0.6025
710,Pantoprazole Sodium,[Na+].COC1=C(OC)C(=NC=C1)\C=S([O-])\C1=NC2=CC(OC(F)F)=CC=C2N1,1.081326531
711,Danaparoid Sodium,CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1O)CO)OS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O)O)O,19.13272727
712,Ziprasidone Hydrochloride,O.Cl.ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=CC=CC=C12,3.41
713,Interferon Beta-1a,n,2.025
714,Chloroquine Hydrochloride,Cl.CCN(CC)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,282
715,Aztreonam,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C2=CSC(N)=N2)C(=O)N1S(O)(=O)=O,2.044773196
716,Desirudin,n,2.205
717,Remimazolam Besylate,OS(=O)(=O)C1=CC=CC=C1.COC(=O)CC[C@@H]1N=C(C2=NC=CC=C2)C2=CC(Br)=CC=C2N2C(C)=CN=C12,0.688
718,Rucaparib Camsylate,[H][C@@]12CC[C@@](CS(O)(=O)=O)(C(=O)C1)C2(C)C.CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23,17
719,Telmisartan,CCCC1=NC2=C(C)C=C(C=C2N1CC1=CC=C(C=C1)C1=CC=CC=C1C(O)=O)C1=NC2=CC=CC=C2N1C,22.33478261
720,Moclobemide,ClC1=CC=C(C=C1)C(=O)NCCN1CCOCC1,1.8
721,Ximelagatran,CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N1CC[C@H]1C(=O)NCC1=CC=C(C=C1)\C=N\NO,0.18
722,Olsalazine Sodium,[Na+].OC1=C(C=C(C=C1)\N=N\C1=CC(C([O-])=O)=C(O)C=C1)C([O-])=O,0.913333333
723,Sebelipase Alfa,n,1.2986875
724,Icatibant Acetate,CC(O)=O.[H][C@@]12CCCC[C@]1([H])N([C@@H](C2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(=O)[C@H]1CC2=CC=CC=C2CN1C(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=CS1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](N)CCCNC(N)=N,2.93643913
725,Ondansetron Hydrochloride,Cl.CN1C2=C(C(=O)C(CC2)CN2C=CN=C2C)C2=C1C=CC=C2,4.062727273
726,Oxybutynin,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,3.585
727,Indomethacin Sodium,[Na+].COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC([O-])=O,13.5
728,Sargramostim,n,2
729,Abacavir Sulfate,OS(O)(=O)=O.NC1=NC2=C(N=CN2[C@@H]2C[C@H](CO)C=C2)C(NC2CC2)=N1,1.006666667
730,Buprenorphine Hydrochloride; Naloxone Hydrochloride,n,16.5
731,Florbetapir F-18,CNC1=CC=C(C=C1)\C=C\C1=CN=C(OCCOCCOCC[18F])C=C1,1.833
732,Trametinib Dimethyl Sulfoxide,CS(C)=O.CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=CC=C(I)C=C1F)C1=CC(NC(C)=O)=CC=C1,349.3333333
733,Frovatriptan Succinate,OC(=O)CCC(O)=O.CN[C@@H]1CCC2=C(C1)C1=C(N2)C=CC(=C1)C(N)=O,26
734,Tolvaptan,CC1=C(C=CC=C1)C(=O)NC1=CC(C)=C(C=C1)C(=O)N1CCCC(O)C2=C1C=CC(Cl)=C2,3.333333333
735,Technetium Tc-99m Albumin Aggregated,n,10.8
736,Amphotericin B Liposome,C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@H]([C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@H]1C)O2)C(O)=O,8.149111111
737,Cangrelor,[Na+].CSCCNC1=NC(SCCC(F)(F)F)=NC2=C1N=CN2[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)C(Cl)(Cl)P([O-])([O-])=O)[C@@H](O)[C@H]1O,0.151888889
738,Tisotumab Vedotin,n,97
739,Amphotericin B,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,216.3866667
740,Ofatumumab,n,341.395
741,Tezosentan,COC1=CC=CC=C1OC1=C(OCCO)N=C(N=C1NS(=O)(=O)C1=NC=C(C=C1)C(C)C)C1=CC(=NC=C1)C1=NN=NN1,3.991666667
742,Loncastuximab Tesirine,n,435.84
743,Azithromycin,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,70.03076923
744,Daunorubicin Citrate,OC(=O)CC(O)(CC(O)=O)C(O)=O.COC1=C2C(=O)C3=C(C(=O)C2=CC=C1)C(O)=C1C[C@](O)(C[C@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1=C3O)C(C)=O,22.13730159
745,Glucagon Recombinant,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CNC=N1)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@H](C)O)C(O)=O,0.1848
746,Pentoxifylline,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C,1
747,Avelumab,n,104.2668966
748,Ramelteon,CCC(=O)NCC[C@@H]1CCC2=CC=C3OCCC3=C12,1.833333333
749,Clevidipine Butyrate,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,0.26658
750,Bepridil Hydrochloride,Cl.CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1,0.9
751,Warfarin Sodium,[Na+].CC(=O)CC(C1=CC=CC=C1)C1=C([O-])C2=C(OC1=O)C=CC=C2,37.26666667
752,Methadone Hydrochloride,Cl.CCC(=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,28.99129032
753,Tesamorelin Acetate,n,0.125
754,Doravirine,CN1C(=O)NN=C1CN1C=CC(=C(OC2=CC(=CC(Cl)=C2)C#N)C1=O)C(F)(F)F,13.10666667
755,Nefopam,CN1CCOC(C2=CC=CC=C2)C2=CC=CC=C2C1,5.1
756,Zolpidem Tartrate,O[C@@H]([C@H](O)C(O)=O)C(O)=O.CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,1.906428571
757,Buprenorphine Hydrochloride,Cl.[H][C@@]1(C[C@@]23CC[C@]1(OC)[C@@H]1OC4=C(O)C=CC5=C4[C@]21CCN(CC1CC1)[C@@H]3C5)[C@](C)(O)C(C)(C)C,5.202222222
758,"Ammonia, N-13",[13NH3],0.0384875
759,Melagatran,NC(=N)C1=CC=C(CNC(=O)[C@@H]2CCN2C(=O)[C@H](NCC(O)=O)C2CCCCC2)C=C1,1.8
760,Omadacycline Tosylate,CC1=CC=C(C=C1)S(O)(=O)=O.[H][C@@]12CC3=C(C=C(CNCC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C,16.4504
761,Rifamycin,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C=C(O)C4=C3C2=O,3.04
762,Almotriptan Malate,OC(CC(O)=O)C(O)=O.CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2,3.4
763,Altretamine,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,6.0935
764,Doxazosin Mesylate,CS(O)(=O)=O.COC1=CC2=NC(=NC(N)=C2C=C1OC)N1CCN(CC1)C(=O)C1COC2=CC=CC=C2O1,11.319375
765,Obiltoxaximab,n,468.0878049
766,Lidocaine; Prilocaine,n,1.646673077
767,Esomeprazole Sodium,[Na+].COC1=CC2=C([N-]C(=N2)S(=O)CC2=C(C)C(OC)=C(C)C=N2)C=C1,1.161166667
768,Glimepiride,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O,3.4
769,Mexiletine Hydrochloride,Cl.CC(N)COC1=C(C)C=CC=C1C,12.53333333
770,Fluvoxamine Maleate,OC(=O)\C=C/C(O)=O.COCCCC\C(C1=CC=C(C=C1)C(F)(F)F)=N/OCCN,12
771,Minocycline Hydrochloride,Cl.[H][C@@]12CC3=C(C(O)=CC=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,15
772,Rivastigmine Tartrate,O[C@H]([C@@H](O)C(O)=O)C(O)=O.CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,1.4
773,Mometasone Furoate Monohydrate,O.[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,9.252307692
774,Moxonidine,COC1=C(NC2=NCCN2)C(Cl)=NC(C)=N1,2.155
775,Hydromorphone Hydrochloride,Cl.[H][C@]12CCC(=O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4O,2.607692308
776,Rotigotine,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1,1.554285714
777,Mirabegron,NC1=NC(CC(=O)NC2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2)=CS1,50
778,Ceftizoxime Sodium,[Na+].CO\N=C(C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C([O-])=O)/C1=CSC(N)=N1,1.638444444
779,Eribulin Mesylate,CS(O)(=O)=O.[H][C@@]12CC[C@@H]3CC(=O)C[C@H]4[C@H](C[C@H]5O[C@@H](CC[C@@H]6O[C@@H](CC[C@]78C[C@@]9([H])O[C@]([H])([C@@]([H])(O1)[C@@]9([H])O7)[C@@]([H])(O8)[C@@]2([H])O3)CC6=C)C[C@@H](C)C5=C)O[C@H](C[C@H](O)CN)[C@@H]4OC,38.58811881
780,Atropine Sulfate,OS(O)(=O)=O.CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,4.921135135
781,Tralokinumab,n,468.32
782,Cefepime Hydrochloride,[Cl-].CO\N=C(C(=O)N[C@H]1[C@H]2SCC(C[N+]3(C)CCCC3)=C(N2C1=O)C(O)=O)\C1=CSC(N)=N1,2.527971014
783,Elosulfase Alfa,n,0.333083333
784,Epirubicin Hydrochloride,Cl.COC1=C2C(=O)C3=C(C(=O)C2=CC=C1)C(O)=C1C[C@](O)(C[C@H](O[C@H]2C[C@H](N)[C@@H](O)[C@H](C)O2)C1=C3O)C(=O)CO,21.44365385
785,Technetium Tc 99m Teboroxime Kit,n,0.100222222
786,Migalastat Hydrochloride,Cl.OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O,4.96
787,Fenoldopam Mesylate,CS(O)(=O)=O.OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12,0.358206897
788,Aspirin; Dipyridamole,n,8.424333333
789,Treosulfan,CS(=O)(=O)OC[C@H](O)[C@@H](O)COS(C)(=O)=O,1.799285714
790,"Strontium Chloride, Sr-89",Cl[89Sr]Cl,586
791,Ketorolac Tromethamine,NC(CO)(CO)CO.OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,5.540769231
792,Cefsulodin,[H][C@@]12SCC(C[N+]3=CC=C(C=C3)C(N)=O)=C(N1C(=O)[C@@H]2NC(=O)C(C1=CC=CC=C1)S(O)(=O)=O)C([O-])=O,5.993333333
793,Mupirocin,[H][C@@]1(C[C@H]2CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]2O)O[C@@]1([H])[C@@H](C)[C@H](C)O,0.333
794,Oliceridine fumarate,OC(=O)\C=C\C(O)=O.COC1=C(CNCC[C@]2(CCOC3(CCCC3)C2)C2=NC=CC=C2)SC=C1,2.470931111
795,Desvenlafaxine Succinate,OC(=O)CCC(O)=O.CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,9.813333333
796,Inamrinone Lactate,CC(O)C(O)=O.NC1=CC(=CNC1=O)C1=CC=NC=C1,3.9
797,Propiverine,CCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1,14.55
798,Ifosfamide,ClCCNP1(=O)OCCCN1CCCl,9.51
799,Allopurinol,O=C1NC=NC2=C1C=NN2,0.797
800,Fluorescein Sodium,[Na+].[O-]C1=CC2=C(C=C1)C1(OC(=O)C3=C1C=CC=C3)C1=C(O2)C=C([O-])C=C1,3
801,Peramivir,O.[H][C@]1([C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O)[C@@H](NC(C)=O)C(CC)CC,16.6325
802,Darbepoetin Alfa,n,21
803,Primaquine Phosphate,OP(O)(O)=O.COC1=CC(NC(C)CCCN)=C2N=CC=CC2=C1,7.1
804,"Doxorubicin, Liposomal",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl,27.3436365
805,Levobupivacaine Hydrochloride,Cl.CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,1.358526316
806,Diatrizoate Meglumine; Diatrizoate Sodium,CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I,2
807,Glasdegib,OC(=O)\C=C/C(O)=O.CN1CC[C@H](C[C@@H]1C1=NC2=C(N1)C=CC=C2)NC(=O)NC1=CC=C(C=C1)C#N,14.1
808,Andexanet Alfa,n,6.4974
809,Lanreotide Acetate,CC(O)=O.CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)NC(=O)[C@H](N)CC1=CC2=CC=CC=C2C=C1,1.831086957
810,Valproate Sodium,[Na+].CCCC(CCC)C([O-])=O,15.68857143
811,Montelukast Sodium,[Na+].CC(C)(O)C1=CC=CC=C1CC[C@@H](SCC1(CC1)CC([O-])=O)C1=CC=CC(\C=C\C2=CC=C3C=CC(Cl)=CC3=N2)=C1,5.084083333
812,Teriparatide (rDNA Origin),CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,0.083
813,Flecainide Acetate,CC(O)=O.FC(F)(F)COC1=CC=C(OCC(F)(F)F)C(=C1)C(=O)NCC1CCCCN1,12.55833333
814,Gadobutrol,[Gd+3].OC[C@H](O)C(CO)N1CCN(CCN(CCN(CC1)CC([O-])=O)CC([O-])=O)CC([O-])=O,1.798571429
815,Alprostadil,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O,0.828818182
816,Laronidase,n,1.698666667
817,Ramucirumab,n,239.71145
818,Teprotumumab,n,480
819,Fluvastatin Sodium,[Na+].CC(C)N1C2=CC=CC=C2C(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O,18.9
820,Alefacept,n,235.4117647
821,Antivenin (Crotalidae) Polyvalent,n,13.5
822,Ethambutol Hydrochloride,Cl.CC[C@H](CO)NCCN[C@H](CC)CO,9.265
823,Fosnetupitant; Palonosetron Hydrochloride,n,24.68833333
824,Neostigmine Bromide,[Br-].CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C,1.28
825,Sarilumab,n,74.63
826,Cefazolin Sodium,[Na+].CC1=NN=C(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)CN2C=NN=N2)C3=O)C([O-])=O)S1,1.816625
827,Insulin (Human Recombinant),n,0.39
828,Filgrastim,n,3.388066667
829,Indacaterol Maleate,OC(=O)\C=C/C(O)=O.CCC1=CC2=C(CC(C2)NC[C@H](O)C2=CC=C(O)C3=C2C=CC(=O)N3)C=C1CC,70.42
830,Suvorexant,C[C@@H]1CCN(CCN1C(=O)C1=CC(C)=CC=C1N1N=CC=N1)C1=NC2=C(O1)C=CC(Cl)=C2,10.7875
831,Zaleplon,CCN(C(C)=O)C1=CC=CC(=C1)C1=CC=NC2=C(C=NN12)C#N,1
832,Lorlatinib,C[C@H]1OC2=CC(=CN=C2N)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=C1C=C(F)C=C2,22.5
833,Dinutuximab,n,219.861
834,Tigecycline,[H][C@@]12CC3=C(C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)C(O)=C(NC(=O)CNC(C)(C)C)C=C3N(C)C,32.01755245
835,Glucarpidase,n,6.081777778
836,Ketoprofen,CC(C(O)=O)C1=CC=CC(=C1)C(=O)C1=CC=CC=C1,2.05
837,Pegvisomant,n,138
838,Vecuronium Bromide,[Br-].[H][C@@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@@H](OC(C)=O)[C@H](C[C@@]34[H])[N+]3(C)CCCCC3)[C@@]1(C)C[C@@H]([C@H](C2)OC(C)=O)N1CCCCC1,0.931862069
839,Eptifibatide,NC(=N)NCCCC[C@@H]1NC(=O)CCSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O)C(N)=O,1.884098901
840,Enfortumab Vedotin,n,81
841,Iobenguane Sulfate I 131,OS(O)(=O)=O.NC(=N)NCC1=CC([131I])=CC=C1,45
842,Ranitidine Hydrochloride,Cl.CN\C(NCCSCC1=CC=C(CN(C)C)O1)=C\N(=O)=O,3.120289157
843,Gallium Ga-68 Psma-11,OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)CCCCCNC(=O)CCC1=CC=C2O[76Ga]3456OC(=O)C[N]3(CC[N]4(CC(=O)O5)CC2=C1)CC1=CC(CCC(O)=O)=CC=C1O6)C(O)=O)C(O)=O,2.255
844,Ketobemidone,CCC(=O)C1(CCN(C)CC1)C1=CC=CC(O)=C1,4.4
845,Clozapine,CN1CCN(CC1)C1=NC2=C(NC3=C1C=CC=C3)C=CC(Cl)=C2,10.3
846,Ethinyl Estradiol,[H][C@]12CC[C@@]3(C)[C@@]([H])(CC[C@@]3(O)C#C)[C@]1([H])CCC1=C2C=CC(O)=C1,9.4
847,Atovaquone,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=C(C=CC=C2)C1=O,62.5
848,Mifepristone,[H][C@@]12CCC3=CC(=O)CCC3=C1[C@H](C[C@@]1(C)[C@@]2([H])CC[C@@]1(O)C#CC)C1=CC=C(C=C1)N(C)C,11.15
849,Palifermin,n,4.434354839
850,Pemetrexed Disodium,[Na+].NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)N1,2.749811321
851,Nedocromil Sodium,[Na+].CCCC1=C2OC(=CC(=O)C2=CC2=C1N(CC)C(=CC2=O)C([O-])=O)C([O-])=O,0.907538462
852,Trilaciclib Dihydrochloride,Cl.CN1CCN(CC1)C1=CN=C(NC2=NC=C3C=C4N(C3=N2)C2(CCCCC2)CNC4=O)C=C1,14
853,Mometasone Furoate,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,4.898571429
854,Acamprosate Calcium,[Ca++].CC(=O)NCCCS([O-])(=O)=O,4.933333333
855,Mycophenolic Acid,COC1=C(C)C2=C(C(=O)OC2)C(O)=C1C\C=C(/C)CCC(O)=O,9.7
856,Technetium Tc-99m Apcitide,n,2.165
857,Pramlintide Acetate,CC(O)=O.CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O,0.557
858,Dactinomycin,CC(C)[C@H]1NC(=O)[C@@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@H]2[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]3CCCN3C(=O)[C@H](NC2=O)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C1=O,27.25
859,Doxapram Hydrochloride,Cl.CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,3.65
860,Furosemide,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C(O)=O,0.698
861,Ceftolozane Sulfate; Tazobactam Sodium,n,2.227631902
862,Imciromab Pentetate,n,20.2
863,Ziconotide,CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC3=O)C(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)[C@@H](C)O,1.3
864,Letermovir,COC1=CC=CC(=C1)N1CCN(CC1)C1=NC2=C(C=CC=C2F)[C@H](CC(O)=O)N1C1=C(OC)C=CC(=C1)C(F)(F)F,14.74363636
865,Melphalan Hydrochloride,Cl.N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,0.920419355
866,Cimetidine,CN\C(NC#N)=N/CCSCC1=C(C)NC=N1,1.85925
867,Grepafloxacin Hydrochloride,Cl.CC1CN(CCN1)C1=CC2=C(C(=O)C(=CN2C2CC2)C(O)=O)C(C)=C1F,8.6
868,Ciclesonide,[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])[C@@H](O)C[C@@]1(C)[C@@]2([H])C[C@H]2O[C@H](O[C@@]12C(=O)COC(=O)C(C)C)C1CCCCC1,0.94
869,Iothalamate Sodium,[Na+].CNC(=O)C1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I,1.5
870,Olopatadine Hydrochloride,Cl.CN(C)CC\C=C1\C2=CC=CC=C2COC2=CC=C(CC(O)=O)C=C12,6.12
871,Aflibercept,n,128.37
872,Darunavir Ethanolate,[H][C@]12OCC[C@@]1([H])[C@H](CO2)OC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1,8.9985
873,Alirocumab,n,149.712
874,Tobramycin Sulfate,OS(O)(=O)=O.[H][C@@]1(O[C@H](CN)[C@@H](O)C[C@H]1N)O[C@H]1[C@H](N)C[C@H](N)[C@@H](O[C@@]2([H])O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O)[C@@H]1O,1.76
875,Ertapenem Sodium,[Na+].[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)NC3=CC(=CC=C3)C([O-])=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,3.978314607
876,Pravastatin Sodium,[Na+].[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC([O-])=O)OC(=O)[C@@H](C)CC,0.78
877,Technetium Tc 99m Depreotide,n,8.9434
878,Nicardipine Hydrochloride,Cl.COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN(C)CC1=CC=CC=C1,0.444714286
879,Darolutamide,C[C@@H](CN1C=CC(=N1)C1=CC=C(C#N)C(Cl)=C1)NC(=O)C1=NNC(=C1)C(C)O,12
880,Granisetron Hydrochloride,Cl.CN1[C@H]2CCC[C@@H]1CC(C2)NC(=O)C1=NN(C)C2=C1C=CC=C2,6.332248062
881,Iothalamate Meglumine,CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC(=O)C1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I,1.31
882,Canakinumab,n,610.683871
883,Ciprofloxacin Hydrochloride; Dexamethasone,n,9
884,Acetylcysteine,CC(=O)N[C@@H](CS)C(O)=O,7.48
885,Meropenem,[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,2.0825
886,Selegiline Hydrochloride,Cl.C[C@H](CC1=CC=CC=C1)N(C)CC#C,0.148
887,Ticarcillin Disodium; Clavulanate Potassium,n,1.046882353
888,Abaloparatide,n,0.87625
889,Apremilast,CCOC1=C(OC)C=CC(=C1)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,6.095
890,Cocaine Hydrochloride,Cl.COC(=O)[C@H]1[C@H](C[C@@H]2CC[C@H]1N2C)OC(=O)C1=CC=CC=C1,1.07
891,Tirofiban Hydrochloride,Cl.CCCCS(=O)(=O)N[C@@H](CC1=CC=C(OCCCCC2CCNCC2)C=C1)C(O)=O,1.913645833
892,Angiotensin II,n,0.017
893,Verapamil Hydrochloride,Cl.COC1=CC=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC=C(OC)C(OC)=C2)C=C1OC,3.439
894,Technetium Tc-99m Mertiatide Kit,n,2.242
895,Diazoxide,CC1=NC2=CC=C(Cl)C=C2S(=O)(=O)N1,28
896,Maprotiline Hydrochloride,Cl.CNCCCC12CCC(C3=C1C=CC=C3)C1=C2C=CC=C1,43
897,Remifentanil Hydrochloride,Cl.CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC(=O)OC)CC1)C(=O)OC,0.105836442
898,Glucocerebrosidase,n,0.0965
899,Methotrexate,CN(CC1=NC2=C(N)N=C(N)N=C2N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,12.79
900,Denosumab,n,496.2
901,Lamivudine,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,1.566666667
902,Procainamide Hydrochloride,Cl.CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,2.842857143
903,Ipratropium Bromide,[Br-].CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,1.710769231
904,Pegcetacoplan,n,228.25
905,Ezogabine,CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1,5.81875
906,Tirilazad Mesylate,CS(O)(=O)=O.[H][C@]12CCC3=CC(=O)C=C[C@]3(C)C1=CC[C@]1(C)[C@H]([C@H](C)C[C@@]21[H])C(=O)CN1CCN(CC1)C1=CC(=NC(=N1)N1CCCC1)N1CCCC1,36.591
907,Zolmitriptan,CN(C)CCC1=CNC2=C1C=C(C[C@H]1COC(=O)N1)C=C2,2.354285714
908,Tetracycline Hydrochloride,Cl.[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,12.23333333
909,Agomelatine,COC1=CC2=C(CCNC(C)=O)C=CC=C2C=C1,0.8
910,Siponimod Fumarate,OC(=O)\C=C\C(O)=O.CCC1=CC(=CC=C1CN1CC(C1)C(O)=O)C(\C)=N\OCC1=CC=C(C2CCCCC2)C(=C1)C(F)(F)F,27
911,Diltiazem Malate; Enalapril Maleate,n,11
912,Ado-Trastuzumab Emtansine,n,95.79090909
913,Azelastine Hydrochloride,Cl.CN1CCCC(CC1)N1N=C(CC2=CC=C(Cl)C=C2)C2=C(C=CC=C2)C1=O,22
914,Atropine Sulfate; Edrophonium Chloride,n,2.166032258
915,Benralizumab,n,329.4288684
916,Budesonide,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(CCC)O2)C(=O)CO,2.035471698
917,Anidulafungin,CCCCCOC1=CC=C(C=C1)C1=CC=C(C=C1)C1=CC=C(C=C1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@@H](C)O,32.19347826
918,Belatacept,n,81.64666667
919,"Interferon Beta-1b, Recombinant",n,0.20175
920,Mannitol,OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,4.216875
921,Rifampin,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(\C=N\N1CCN(C)CC1)=C2O,3.626428571
922,Secukinumab,n,686.3085106
923,Flumazenil,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1,0.766888889
924,Tapentadol Hydrochloride,Cl.CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1,4.07
925,Ciprofloxacin Hydrochloride,Cl.OC(=O)C1=CN(C2CC2)C2=C(C=C(F)C(=C2)N2CCNCC2)C1=O,4.381282051
926,Docetaxel,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C4=CC=CC=C4)C(C)=C([C@@H](O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,8.294
927,Ibandronate Sodium,[Na+].CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)([O-])=O,16.72787879
928,Nicotinic Acid; Laropiprant,n,15
929,Rosuvastatin Calcium,[Ca++].CC(C)C1=C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)C(=NC(=N1)N(C)S(C)(=O)=O)C1=CC=C(F)C=C1,3.396
930,Bivalirudin,O.OC(=O)C(F)(F)F.CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,1.185077922
931,Raloxifene Hydrochloride,Cl.OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,12.1
932,Enoxacin,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N=C12)N1CCNCC1,4.48
933,Nicotine,CN1CCC[C@H]1C1=CC=CN=C1,2.062147222
934,Mangafodipir Trisodium,[Na+].CC1=NC=C(COP(O)([O-])=O)C(C[N]23CC[N]4(CC(=O)O[Mn]24OC(=O)C3)CC2=C(O)C(C)=NC=C2COP([O-])([O-])=O)=C1O,1.101904762
935,Leuprolide Acetate,CC(O)=O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,3
936,Tramadol Hydrochloride,Cl.COC1=CC(=CC=C1)[C@]1(O)CCCC[C@H]1CN(C)C,10.79411765
937,Nivolumab,n,585.4567164
938,"Coagulation Factor XA (Recombinant), Inactivated",n,5.606291667
939,Cefprozil,C\C=C\C1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C1=CC=C(O)C=C1)C2=O)C(O)=O,1.473333333
940,Calcipotriene,[H][C@@]1(CC[C@]2([H])[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@@H](O)C1CC1,0.466666667
941,Trimethoprim,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC,11.2025
942,Ascorbic Acid,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O,7.181368421
943,Tobramycin,[H][C@@]1(O[C@H](CN)[C@@H](O)C[C@H]1N)O[C@H]1[C@H](N)C[C@H](N)[C@@H](O[C@@]2([H])O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O)[C@@H]1O,2.125285714
944,"Interferon Alfa-2a, Recombinant",n,5.1
945,"Recombinant Human Coagulation Factor IX, Fc Fusion Protein (rFIXFc)",n,76.32
946,Esomeprazole Magnesium,[Mg++].COC1=CC=C2[N-]C(=NC2=C1)[S@@](=O)CC1=NC=C(C)C(OC)=C1C,1.2
947,Isavuconazonium Sulfate,OS([O-])(=O)=O.CNCC(=O)OCC1=CC=CN=C1N(C)C(=O)OC(C)[N+]1=CN(C[C@@](O)([C@@H](C)C2=NC(=CS2)C2=CC=C(C=C2)C#N)C2=C(F)C=CC(F)=C2)N=C1,107.5547222
948,Nimustine,CC1=NC=C(CNC(=O)N(CCCl)N=O)C(N)=N1,0.6765
949,Phytonadione,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CC1=C(C)C(=O)C2=CC=CC=C2C1=O,1.615
950,Felodipine,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,7.383964286
951,Lomefloxacin Hydrochloride,Cl.CCN1C=C(C(O)=O)C(=O)C2=C1C(F)=C(N1CCNC(C)C1)C(F)=C2,8.6
952,Bleomycin Sulfate,[O-]S([O-])(=O)=O.C[C@@H](O)[C@H](NC(=O)[C@@H](C)[C@H](O)[C@@H](C)NC(=O)[C@@H](NC(=O)C1=C(C)C(N)=NC(=N1)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)C1=CNC=N1)C(=O)NCCC1=NC(=CS1)C1=NC=C(S1)C(N)=O,3.024934783
953,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC1=CC=CC=C1)C1=CC=CC=C1,8.473037037
954,Satavaptan,CCOC1=CC2=C(C=C1)N(SC1=CC=C(C=C1OC)C(=O)NC(C)(C)C)C(=O)[C@@]21CC[C@@H](CC1)OCCN1CCOCC1,12.31428571
955,Drotrecogin Alfa,n,1.6
956,Carboplatin,[NH3][Pt]1([NH3])OC(=O)C2(CCC2)C(=O)O1,2.6
957,Vildagliptin,[H][C@]12C[C@]3([H])C[C@](O)(C1)C[C@](C2)(C3)NCC(=O)N1CCC[C@@H]1C#N,2
958,Ketamine Hydrochloride,Cl.CNC1(CCCCC1=O)C1=CC=CC=C1Cl,1.719857143
959,Follitropin Alfa,n,17.88888889
960,Bevacizumab,n,401.1969767
961,Terazosin Hydrochloride,Cl.COC1=CC2=NC(=NC(N)=C2C=C1OC)N1CCN(CC1)C(=O)C1CCCO1,10.63181818
962,Amphotericin B Lipid Complex,n,150.95
963,Zalcitabine,NC1=NC(=O)N(C=C1)[C@H]1CC[C@@H](CO)O1,2.023076923
964,Pemetrexed Diacid,NC1=NC2NC=C(CCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C2C(=O)N1,3.5
965,Procyclidine Hydrochloride,Cl.OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1,11.5
966,Methimazole,CN1C=CNC1=S,4.578
967,Sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,8.925
968,Ziv-Aflibercept,n,144
969,Methylprednisolone Sodium Succinate,[Na+].[H][C@@]12C[C@H](C)C3=CC(=O)C=C[C@]3(C)[C@@]1([H])[C@@H](O)C[C@@]1(C)[C@@]2([H])CC[C@]1(O)C(=O)COC(=O)CCC([O-])=O,2.369695652
970,Dexrazoxane Hydrochloride,Cl.C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,2.426659091
971,Roflumilast,FC(F)OC1=CC=C(C=C1OCC1CC1)C(=O)NC1=C(Cl)C=NC=C1Cl,13.03
972,Tasonermin,n,0.305333333
973,Polatuzumab Vedotin,n,288
974,Mogamulizumab,n,412.6666667
975,Pinacidil,CC(C(C)(C)C)\N=C(/NC#N)NC1=CC=NC=C1,2.13
976,Ketanserin,FC1=CC=C(C=C1)C(=O)C1CCN(CC1)CCN1C(=O)NC2=C(C=CC=C2)C1=O,5.65
977,Avalglucosidase Alfa,n,1.333333333
978,Imipenem; Cilastatin; Relebactam,n,1.6176
979,Sulbactam,[H][C@@]12CC(=O)N1[C@@H](C(O)=O)C(C)(C)S2(=O)=O,1.936666667
980,Verteporfin,COC(=O)CCC1=C(C)C2=N/C/1=C\C1=C(CCC(O)=O)C(C)=C(N1)\C=C1/N=C(/C=C3N\C(=C/2)[C@]2(C)[C@H](C(=O)OC)C(=CC=C\32)C(=O)OC)C(C)=C/1C=C,5.225057471
981,Apomorphine Hydrochloride,Cl.[H][C@@]12CC3=CC=C(O)C(O)=C3C3=C1C(CCN2C)=CC=C3,0.7266
982,Amikacin Sulfate,OS(O)(=O)=O.NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,2.912
983,Arsenic Trioxide,O1[As]2O[As]1O2,61.04615385
984,Regadenoson,O.CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,1.7978125
985,Florbetaben F-18,CNC1=CC=C(C=C1)\C=C\C1=CC=C(OCCOCCOCC[18F])C=C1,1
986,Trimetrexate Glucuronate,O[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O.COC1=CC(NCC2=C(C)C3=C(N)N=C(N)N=C3C=C2)=CC(OC)=C1OC,13.13185185
987,Clopidogrel Bisulfate,OS(O)(=O)=O.COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C1=CC=CC=C1Cl,108
988,Clonazepam,ClC1=CC=CC=C1C1=NCC(=O)NC2=CC=C(C=C12)N(=O)=O,16.33
989,Oxacillin Sodium,[Na+].[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C([O-])=O,0.4165
990,Trospium Chloride,[Cl-].OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]21CCCC1)(C1=CC=CC=C1)C1=CC=CC=C1,8.2675
991,Valproic Acid,CCCC(CCC)C(O)=O,12.35
992,Fospropofol Disodium,[Na+].CC(C)C1=CC=CC(C(C)C)=C1OCOP([O-])([O-])=O,1.276571429
993,Bosutinib Monohydrate,O.COC1=C(Cl)C=C(Cl)C(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C1,35.5
994,Cidofovir,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,2.564444444
995,"Proteinase Inhibitor (Human), Alpha 1",n,123.36
996,Ropivacaine Hydrochloride Monohydrate,O.Cl.CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,1.923023256
997,Ribavirin,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,18.74
998,Valbenazine Tosylate,CC1=CC=C(C=C1)S(O)(=O)=O.[H][C@]12C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CCC1=CC(OC)=C(OC)C=C21,16
999,Hydroxyurea,NC(=O)NO,3.355
1000,Cobimetinib Fumarate,OC(=O)\C=C\C(O)=O.OC1(CN(C1)C(=O)C1=CC=C(F)C(F)=C1NC1=C(F)C=C(I)C=C1)[C@@H]1CCCCN1,58.8
1001,Treprostinil Diolamine,OCCNCCO.[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=CC=CC(OCC(O)=O)=C1C2,1.515
1002,Etelcalcetide Hydrochloride,Cl.C[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@H](N)C(O)=O)NC(C)=O)C(=O)N[C@H](CCCNC(N)=N)C(N)=O,83.77666667
1003,Gadoteridol,CC(O)CN1CCN2CCN3CCN(CC1)CC(=O)O[Gd](OC(=O)C2)OC(=O)C3,1.57
1004,Nitrendipine,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)N(=O)=O)C(=O)OC,4
1005,Certolizumab Pegol,n,290.4
1006,Avibactam Sodium; Ceftazidime,n,2.294615385
1007,Abciximab,n,0.5
1008,Capromab Pendetide,n,67
1009,Menotropins,CC(C)(C)CCCCC=O,12.995
1010,Tenecteplase,n,1.12765
1011,Amivantamab,n,271.2
1012,Crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C(F)=CC=C1Cl,38.86
1013,Gadoversetamide,COCCNC(=O)CN1CCN2CCN(CC(=O)NCCOC)CC(=O)O[Gd](OC(=O)C2)OC(=O)C1,1.816754545
1014,"Interferon Gamma-1b, Recombinant",n,0.633
1015,Aminolevulinic Acid Hydrochloride,Cl.NCC(=O)CCC(O)=O,0.83
1016,Tolterodine Tartrate,O[C@H]([C@@H](O)C(O)=O)C(O)=O.CC(C)N(CC[C@H](C1=CC=CC=C1)C1=CC(C)=CC=C1O)C(C)C,2.94
1017,Ixekizumab,n,312
1018,Voriconazole,C[C@@H](C1=C(F)C=NC=N1)[C@](O)(CN1C=NC=N1)C1=CC=C(F)C=C1F,6.992307692
1019,Tinidazole,CCS(=O)(=O)CCN1C(C)=NC=C1N(=O)=O,12.25454545
1020,Fluorouracil,FC1=CNC(=O)NC1=O,0.60921
1021,Acebutolol Hydrochloride,Cl.CCCC(=O)NC1=CC=C(OCC(O)CNC(C)C)C(=C1)C(C)=O,4.7733125
1022,Romiplostim,n,5.901666667
1023,Oxytocin,[H][C@]1(CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O,0.017
1024,Alosetron Hydrochloride,Cl.CN1C2=C(C(=O)N(CC2)CC2=C(C)NC=N2)C2=C1C=CC=C2,1.642407407
1025,Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1,14.33333333
1026,Pralidoxime Chloride,[Cl-].C[N+]1=CC=CC=C1\C=N\O,2.4
1027,Gemcitabine Hydrochloride,Cl.NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,1.904885522
1028,Aripiprazole,ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl,98.93333333
1029,Fenoterol,CC(CC1=CC=C(O)C=C1)NCC(O)C1=CC(O)=CC(O)=C1,0.86325
1030,Evolocumab,n,264
1031,Ampicillin,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,1.16925
1032,Metronidazole,CC1=NC=C(N1CCO)N(=O)=O,7.6536
1033,Piperacillin Sodium,[Na+].[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=CC=C1)C([O-])=O,0.986382353
1034,Oxymorphone Hydrochloride,Cl.[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@H](C4)[C@]1(O)CCC2=O,1.3
1035,Dobutamine Hydrochloride,Cl.CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1,0.041833333
1036,Ziprasidone Mesylate,O.CS(O)(=O)=O.ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=CC=CC=C12,3.14
1037,Lansoprazole,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,1.23
1038,"Interferon Alfa-2b, Recombinant",n,2
1039,Linagliptin,CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=CC=CC=C3C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1,131.1111111
1040,Teriflunomide,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,465.6
1041,Arbutamine Hydrochloride,Cl.O[C@@H](CNCCCCC1=CC=C(O)C=C1)C1=CC(O)=C(O)C=C1,0.134
1042,Chlordiazepoxide Hydrochloride,Cl.CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=N(=O)C1,10.12375
1043,Nafcillin Sodium,[Na+].CCOC1=CC=C2C=CC=CC2=C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C([O-])=O,0.466
1044,Rilonacept,n,188.8738462
1045,Mesna,[Na+].[O-]S(=O)(=O)CCS,1.33175
1046,Mycophenolate Mofetil,COC1=C(C)C2=C(C(=O)OC2)C(O)=C1C\C=C(/C)CCC(=O)OCCN1CCOCC1,16.6
1047,Calaspargase Pegol,n,385.2
1048,Paliperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C(=O)N2CCCC(O)C2=N1,24.6
1049,Ponesimod,CCC\N=C1/S\C(=C/C2=CC=C(OC[C@H](O)CO)C(Cl)=C2)C(=O)N1C1=CC=CC=C1C,33
1050,Rolapitant Hydrochloride,Cl.C[C@@H](OC[C@]1(CC[C@]2(CCC(=O)N2)CN1)C1=CC=CC=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,164.0017778
1051,Tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1,7.247465116
1052,Irinotecan Liposome,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12)[C@@](O)(CC)C(=O)OC4,20.88
1053,Fluticasone Propionate,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,6.161333333
1054,Necitumumab,n,167.3614815
1055,Bosentan,COC1=CC=CC=C1OC1=C(OCCO)N=C(N=C1NS(=O)(=O)C1=CC=C(C=C1)C(C)(C)C)C1=NC=CC=N1,4.06
1056,Zopiclone,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=NC=C(Cl)C=C1,4.925
1057,Zidovudine,CC1=CN([C@H]2C[C@H](N=N#N)[C@@H](CO)O2)C(=O)NC1=O,1.215172414
1058,Alfentanil Hydrochloride,Cl.CCN1N=NN(CCN2CCC(CC2)(COC)N(C(=O)CC)C2=CC=CC=C2)C1=O,1.288183673
1059,Fenfluramine Hydrochloride,Cl.CCNC(C)CC1=CC=CC(=C1)C(F)(F)F,14.9
1060,Infliximab,n,204.8710526
1061,Mipomersen Sodium,n,1.022
1062,Alvimopan,C[C@H]1CN(CC[C@@]1(C)C1=CC(O)=CC=C1)C[C@H](CC1=CC=CC=C1)C(=O)NCC(O)=O,5.3
1063,Temozolomide,CN1N=NC2=C(N=CN2C1=O)C(N)=O,1.7276
1064,Clofarabine,NC1=NC(Cl)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F,5.506896552
1065,Fludarabine Phosphate,NC1=NC(F)=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O,17.98
1066,Gadopentetate Dimeglumine,CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN1CCN2CCN(CC(O)=O)CC(=O)O[Gd](OC(=O)C2)OC(=O)C1,1.6
1067,Articaine Hydrochloride; Epinephrine Bitartrate,n,24.03333333
1068,Viloxazine,CCOC1=CC=CC=C1OCC1CNCCO1,4.1
1069,Fosphenytoin Sodium,[Na+].[O-]P([O-])(=O)OCN1C(=O)NC(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,0.229229167
1070,Phenylephrine Hydrochloride,Cl.CNC[C@H](O)C1=CC=CC(O)=C1,1.025142857
1071,Corticorelin Ovine Triflutate,OC(=O)C(F)(F)F.CC[C@H](C)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(N)=O,0.683615385
1072,Levoleucovorin Calcium,[Ca++].NC1=NC2=C(N(C=O)[C@@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)CN2)C(O)=N1,5.1
1073,Doxorubicin Hydrochloride,Cl.COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,35.90724528
1074,Galsulfase,n,0.244308571
1075,Moxalactam Disodium,[Na+].[H][C@]12OCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C(C([O-])=O)C1=CC=C(O)C=C1)OC)C([O-])=O,2.031333333
1076,Dabrafenib Mesylate,CS(O)(=O)=O.CC(C)(C)C1=NC(=C(S1)C1=CC=NC(N)=N1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1,2.6
1077,Rubidium Chloride Rb-82,Cl[82Rb],0.0208
1078,Sodium Thiosulfate,[Na+].[H]O[H].[O-]S([O-])(=O)=S,1.683
1079,Lesinurad,OC(=O)CSC1=NN=C(Br)N1C1=C2C=CC=CC2=C(C=C1)C1CC1,22.1
1080,Cetrorelix,CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,9
1081,Levocarnitine,C[N+](C)(C)C[C@H](O)CC([O-])=O,12.245
1082,Gallium Nitrate,O=N(=O)O[Ga](ON(=O)=O)ON(=O)=O,19.675
1083,Burosumab,n,228
1084,Colchicine,COC1=CC=C2C(=CC1=O)[C@H](CCC1=CC(OC)=C(OC)C(OC)=C21)NC(C)=O,67.26666667
1085,Cefotiam Hydrochloride,Cl.[H][C@]12SCC(CSC3=NN=NN3CCN(C)C)=C(N1C(=O)[C@H]2NC(=O)CC1=CSC(N)=N1)C(O)=O,0.76764
1086,"Follitropin Alfa, Beta",n,15.75
1087,Immune Globulin Subcutaneous (Human),n,512.4
1088,Ranolazine,COC1=CC=CC=C1OCC(O)CN1CCN(CC1)CC(=O)NC1=C(C)C=CC=C1C,2.210833333
1089,"Fludeoxyglucose, F-18",OC[C@H]1O[C@H](O)[C@H]([18F])[C@@H](O)[C@@H]1O,1.47
1090,Iron Sucrose,[Fe].OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,6.043157895
1091,Sulfamethoxazole; Trimethoprim,n,10.8475
1092,Allopurinol Sodium,[Na+].[O-]C1=NC=NC2=C1C=NN2,0.888058824
1093,Dronedarone Hydrochloride,Cl.CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=CC=C(NS(C)(=O)=O)C=C12,11.67384615
1094,Glucagon,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CNC=N1)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@H](C)O)C(O)=O,0.0661
1095,Lurbinectedin,[H][C@@]12CC3=C(C(O)=C(OC)C(C)=C3)[C@@]([H])(N1C)[C@@]1([H])N([C@H]2O)[C@@]2([H])COC(=O)[C@]3(CS[C@]1([H])C1=C(OC(C)=O)C(C)=C4OCOC4=C21)NCCC1=C3NC2=C1C=C(OC)C=C2,51
1096,Adalimumab,n,311.4888889
